🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:

Response:

Calculated Shard: 181 (from laksa072)

2. Crawled Status Check

Query:

curl -X POST \
  'http://laksa181.int.ahrefs:8124/' \
  -H 'Content-Type: text/plain' \
  -H 'X-ClickHouse-Database: crawler3' \
  -H 'Authorization: Basic YXBpOg==' \
  -d 'SELECT getAhrefsURLFromUnparsed(src_unparsed) AS found_url, ifNull(toUnixTimestamp(download_stamp), 0) AS crawl_time, ifNull(toUnixTimestamp(props_url_first_seen), 0) AS first_indexed_time, download_http_code AS http_code, src_unparsed AS src_unparsed, src_root_hash AS src_root_hash, history_drop_reason AS history_drop_reason, meta_title AS meta_title, meta_descriptions AS meta_descriptions, attrs_boilerpipe_text AS attrs_boilerpipe_text, attrs_markdown AS attrs_markdown, attrs_readable_markdown AS attrs_readable_markdown, meta_canonical AS meta_canonical FROM crawler3.page_info_local FINAL PREWHERE (src_root_hash, src_unparsed) IN ((getAhrefsRootHashFromUnparsed(getAhrefsUnparsedNoserviceFromURL(\'https://markets.businessinsider.com/stocks/moh-stock\')), getAhrefsUnparsedNoserviceFromURL(\'https://markets.businessinsider.com/stocks/moh-stock\'))) FORMAT JSONEachRow'

Response:

{"found_url":"https:\/\/markets.businessinsider.com\/stocks\/moh-stock","crawl_time":1773189540,"first_indexed_time":1534888099,"http_code":200,"src_unparsed":"com,businessinsider!markets,\/stocks\/moh-stock s443","src_root_hash":"15170859634011428381","history_drop_reason":null,"meta_title":"Molina Healthcare Stock Price | MOH Stock Quote, News, and History | Markets Insider","meta_descriptions":["The latest Molina Healthcare stock prices, stock quotes, news, and MOH history to help you invest and trade smarter."],"attrs_boilerpipe_text":"Price\nAnalyst:\nWells Fargo & Co\nPrice-Target:\n440\nRating:\nneutral\nAnalyst:\nBank of America Merrill Lynch\nPrice-Target:\n439\nRating:\nsell\nAnalyst:\nBank of America Merrill Lynch\nPrice-Target:\n439\nRating:\nsell\nAnalyst:\nCantor Fitzgerald\nPrice-Target:\n406\nRating:\nbuy\nAnalyst:\nWells Fargo & Co\nPrice-Target:\n410\nRating:\nneutral\nAnalyst:\nBarclays Capital\nPrice-Target:\n430\nRating:\nneutral\nAnalyst:\nStephens Inc.\nPrice-Target:\n390\nRating:\nneutral\nAnalyst:\nWells Fargo & Co\nPrice-Target:\n375\nRating:\nneutral\nAnalyst:\nBaird Patrick & Co\nPrice-Target:\n405\nRating:\nbuy\nAnalyst:\nJ.P. Morgan\nPrice-Target:\n420\nRating:\nbuy\nAnalyst:\nJ.P. Morgan\nPrice-Target:\n395\nRating:\nbuy\nAnalyst:\nWells Fargo & Co\nPrice-Target:\n315\nRating:\nneutral\nAnalyst:\nCantor Fitzgerald\nPrice-Target:\n406\nRating:\nbuy\nAnalyst:\nJefferies & Company Inc.\nPrice-Target:\n297\nRating:\nneutral\nAnalyst:\nStephens Inc.\nPrice-Target:\n320\nRating:\nneutral\nAnalyst:\nDeutsche Bank\nPrice-Target:\n353\nRating:\nneutral\nAnalyst:\nStephens Inc.\nPrice-Target:\n345\nRating:\nneutral\nAnalyst:\nUBS\nPrice-Target:\n325\nRating:\nneutral\nAnalyst:\nBarclays Capital\nPrice-Target:\n339\nRating:\nneutral\nAnalyst:\nMizuho\nPrice-Target:\n376\nRating:\nbuy\nAnalyst:\nWells Fargo & Co\nPrice-Target:\n372\nRating:\nbuy\nAnalyst:\nMizuho\nPrice-Target:\n400\nRating:\nbuy\nAnalyst:\nBaird Patrick & Co\nPrice-Target:\n375\nRating:\nneutral\nAnalyst:\nBernstein\nPrice-Target:\n414\nRating:\nbuy\nAnalyst:\nBarclays Capital\nPrice-Target:\n362\nRating:\nneutral\nAnalyst:\nBarclays Capital\nPrice-Target:\n351\nRating:\nneutral\nAnalyst:\nBarclays Capital\nPrice-Target:\n347\nRating:\nneutral\nAnalyst:\nMorgan Stanley\nPrice-Target:\n364\nRating:\nbuy\nAnalyst:\nMorgan Stanley\nPrice-Target:\n266\nRating:\nneutral\nAnalyst:\nMizuho\nPrice-Target:\n330\nRating:\nbuy\nAnalyst:\nWells Fargo & Co\nPrice-Target:\n216\nRating:\nbuy\nAnalyst:\nBaird Patrick & Co\nPrice-Target:\n179\nRating:\nneutral\nAnalyst:\nBarclays Capital\nPrice-Target:\n186\nRating:\nneutral\nAnalyst:\nCantor Fitzgerald\nPrice-Target:\n210\nRating:\nneutral\nAnalyst:\nUBS\nPrice-Target:\n180\nRating:\nneutral\nAnalyst:\nJ.P. Morgan\nPrice-Target:\n184\nRating:\nneutral\nAnalyst:\nWells Fargo & Co\nPrice-Target:\n198\nRating:\nbuy\nAnalyst:\nCantor Fitzgerald\nPrice-Target:\n210\nRating:\nneutral\nAnalyst:\nBarclays Capital\nPrice-Target:\n185\nRating:\nneutral\nAnalyst:\nBernstein\nPrice-Target:\n220\nRating:\nbuy\nAnalyst:\nWells Fargo & Co\nPrice-Target:\n231\nRating:\nbuy\nAnalyst:\nMorgan Stanley\nPrice-Target:\n204\nRating:\nneutral\nAnalyst:\nGoldman Sachs\nPrice-Target:\n207\nRating:\nneutral\nAnalyst:\nBarclays Capital\nPrice-Target:\n144\nRating:\nsell\nAnalyst:\nUBS\nPrice-Target:\n170\nRating:\nneutral\nAnalyst:\nCantor Fitzgerald\nPrice-Target:\n180\nRating:\nneutral\nAnalyst:\nGoldman Sachs\nPrice-Target:\n167\nRating:\nneutral\nAnalyst:\nWells Fargo & Co\nPrice-Target:\n165\nRating:\nbuy\nAnalyst:\nBarclays Capital\nPrice-Target:\n164\nRating:\nsell\nAnalyst:\nWells Fargo & Co\nPrice-Target:\n208\nRating:\nbuy\nAnalyst:\nCantor Fitzgerald\nPrice-Target:\n144\nRating:\nneutral\nAnalyst:\nBarclays Capital\nPrice-Target:\n133\nRating:\nsell\nAnalyst:\nGoldman Sachs\nPrice-Target:\n124\nRating:\nneutral\nAnalyst:\nWells Fargo & Co\nPrice-Target:\n141\nRating:\nneutral\nAnalyst:\nMorgan Stanley\nPrice-Target:\n128\nRating:\nneutral","attrs_markdown":"![](data:image\/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiPz48c3ZnIHdpZHRoPSI5OTk5OXB4IiBoZWlnaHQ9Ijk5OTk5cHgiIHZpZXdCb3g9IjAgMCA5OTk5OSA5OTk5OSIgdmVyc2lvbj0iMS4xIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHhtbG5zOnhsaW5rPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rIj48ZyBzdHJva2U9Im5vbmUiIGZpbGw9Im5vbmUiIGZpbGwtb3BhY2l0eT0iMCI+PHJlY3QgeD0iMCIgeT0iMCIgd2lkdGg9Ijk5OTk5IiBoZWlnaHQ9Ijk5OTk5Ij48L3JlY3Q+IDwvZz4gPC9zdmc+)\n\n[My Markets Watchlist](https:\/\/markets.businessinsider.com\/mymarkets?originurl=\/stocks\/moh-stock)\n\n[DOW 30 -0.07%-34.2947,706.51](https:\/\/markets.businessinsider.com\/index\/dow_jones)\n\n[S\\&P 500 -0.21%-14.506,793.50](https:\/\/markets.businessinsider.com\/index\/s&p_500)\n\n[NASDAQ 100 -0.04%-10.7824,956.47](https:\/\/markets.businessinsider.com\/index\/nasdaq_100)\n\n[gold +0.40%+20.905,209.27](https:\/\/markets.businessinsider.com\/commodities\/gold-price)\n\n[oil (wti) -0.84%-0.7082.75](https:\/\/markets.businessinsider.com\/commodities\/oil-price?type=wti)\n\n[BTC\/USD +0.27%+191.8670,093.26](https:\/\/markets.businessinsider.com\/currencies\/btc-usd)\n\n[DOW 30 -0.07%-34.2947,706.51](https:\/\/markets.businessinsider.com\/index\/dow_jones)\n\n[S\\&P 500 -0.21%-14.506,793.50](https:\/\/markets.businessinsider.com\/index\/s&p_500)\n\n[NASDAQ 100 -0.04%-10.7824,956.47](https:\/\/markets.businessinsider.com\/index\/nasdaq_100)\n\n[gold +0.40%+20.905,209.27](https:\/\/markets.businessinsider.com\/commodities\/gold-price)\n\n[oil (wti) -0.84%-0.7082.75](https:\/\/markets.businessinsider.com\/commodities\/oil-price?type=wti)\n\n[BTC\/USD +0.27%+191.8670,093.26](https:\/\/markets.businessinsider.com\/currencies\/btc-usd)\n\n[Markets](https:\/\/markets.businessinsider.com\/)\n\n[Stocks](https:\/\/markets.businessinsider.com\/stocks)\n\n[Business](https:\/\/www.businessinsider.com\/business)\n\n[Strategy](https:\/\/www.businessinsider.com\/strategy)\n\n[Economy](https:\/\/www.businessinsider.com\/economy)\n\n[Finance](https:\/\/www.businessinsider.com\/finance)\n\n[Retail](https:\/\/www.businessinsider.com\/retail)\n\n[Advertising](https:\/\/www.businessinsider.com\/advertising)\n\n[Careers](https:\/\/www.businessinsider.com\/careers)\n\n[Media](https:\/\/www.businessinsider.com\/media)\n\n[Real Estate](https:\/\/www.businessinsider.com\/real-estate)\n\n[Small Business](https:\/\/www.businessinsider.com\/smallbusiness)\n\n[The Better Work Project](https:\/\/www.businessinsider.com\/sc\/introducing-the-better-work-project-hub)\n\n[Personal Finance](https:\/\/www.businessinsider.com\/personal-finance)\n\n[Tech](https:\/\/www.businessinsider.com\/tech)\n\n[Science](https:\/\/www.businessinsider.com\/science)\n\n[AI](https:\/\/www.businessinsider.com\/artificial-intelligence)\n\n[Enterprise](https:\/\/www.businessinsider.com\/enterprise)\n\n[Transportation](https:\/\/www.businessinsider.com\/transportation)\n\n[Startups](https:\/\/www.businessinsider.com\/startups)\n\n[Innovation](https:\/\/www.businessinsider.com\/innovation)\n\n[Markets](https:\/\/markets.businessinsider.com\/)\n\n[Stocks](https:\/\/markets.businessinsider.com\/stocks)\n\n[Indices](https:\/\/markets.businessinsider.com\/indices)\n\n[Commodities](https:\/\/markets.businessinsider.com\/commodities)\n\n[Crypto](https:\/\/markets.businessinsider.com\/cryptocurrencies)\n\n[Currencies](https:\/\/markets.businessinsider.com\/currencies)\n\n[ETFs](https:\/\/markets.businessinsider.com\/etfs)\n\n[Lifestyle](https:\/\/www.businessinsider.com\/lifestyle)\n\n[Entertainment](https:\/\/www.businessinsider.com\/entertainment)\n\n[Culture](https:\/\/www.businessinsider.com\/culture)\n\n[Travel](https:\/\/www.businessinsider.com\/travel)\n\n[Food](https:\/\/www.businessinsider.com\/food)\n\n[Health](https:\/\/www.businessinsider.com\/health)\n\n[Parenting](https:\/\/www.businessinsider.com\/parenting)\n\n[Politics](https:\/\/www.businessinsider.com\/politics)\n\n[Military & Defense](https:\/\/www.businessinsider.com\/defense)\n\n[Law](https:\/\/www.businessinsider.com\/law)\n\n[Education](https:\/\/www.businessinsider.com\/education)\n\n[Reviews](https:\/\/www.businessinsider.com\/guides)\n\n[Home](https:\/\/markets.businessinsider.com\/guides\/home)\n\n[Kitchen](https:\/\/markets.businessinsider.com\/guides\/kitchen)\n\n[Style](https:\/\/markets.businessinsider.com\/guides\/style)\n\n[Streaming](https:\/\/markets.businessinsider.com\/guides\/streaming)\n\n[Pets](https:\/\/markets.businessinsider.com\/guides\/pets)\n\n[Tech](https:\/\/markets.businessinsider.com\/guides\/tech)\n\n[Deals](https:\/\/markets.businessinsider.com\/guides\/deals)\n\n[Gifts](https:\/\/markets.businessinsider.com\/guides\/gifts)\n\n[Tickets](https:\/\/markets.businessinsider.com\/guides\/tickets)\n\n[Video](https:\/\/www.businessinsider.com\/video)\n\n[Big Business](https:\/\/www.businessinsider.com\/show\/big-business)\n\n[Food Wars](https:\/\/www.businessinsider.com\/show\/food-wars)\n\n[So Expensive](https:\/\/www.businessinsider.com\/show\/so-expensive)\n\n[Still Standing](https:\/\/www.businessinsider.com\/show\/still-standing)\n\n[Boot Camp](https:\/\/www.businessinsider.com\/show\/boot-camp)\n\n# Molina HealthcareStock , MOH\n141\\.32\\-4.73\\-3.24%\n\n03:59:59 PM\n\nBTT\n\nAdd to watchlist\n\n|   |   |   |   |   |\n|---|---|---|---|---|\n| [News](https:\/\/markets.businessinsider.com\/stocks\/moh-stock#instrument-detail-news) | [Analyst Data](https:\/\/markets.businessinsider.com\/stocks\/moh-stock#analyst) | [Analyst Opinions](https:\/\/markets.businessinsider.com\/stocks\/moh-stock#analyst_opinions) | [Insider Activity](https:\/\/markets.businessinsider.com\/stocks\/moh-stock#insider_activity) | [Dividend Calendar](https:\/\/markets.businessinsider.com\/stocks\/moh-stock#dividend_calendar) |\n\n\n\nintraday\n\n1w\n\n1m\n\n6m\n\nytd\n\n1y\n\n3y\n\n5y\n\nmax\n\nIndicators\n\n- Moving Average\n- Momentum\n- MACD\n- Stochastics\n- RSI\n- Bollinger Bands\n- Supertrend\n- Average True R.\n- Volume\n\nMountain-Chart\n\n- Mountain-Chart\n- Line-Chart\n- OHLC-Chart\n- Candlestick-Chart\n- Advanced Chart\n\nsavecancel\n\n(right-click to deleteright-click to manage)(long-press to drag)\n\nDate\n\nCompare with\n\nRemove all\n\nCompare with up to 5 Stocks\n\nOn Tuesday 03\/10\/2026 the closing price of the Molina Healthcare share was \\$141.32 on BTT. Compared to the opening price on Tuesday 03\/10\/2026 on BTT of \\$146.28, this is a drop of 3.51%. Molina Healthcare's market capitalization is \\$5.83 B by 51.50 M shares outstanding.\n\nIs Molina Healthcare stock a Buy, Sell or Hold?\n\nMolina Healthcare stock has received a consensus rating of hold. The average rating score is and is based on 17 buy ratings, 33 hold ratings, and 5 sell ratings.\n\nWhat was the 52-week low for Molina Healthcare stock?\n\nThe low in the last 52 weeks of Molina Healthcare stock was 121.16. According to the current price, Molina Healthcare is 116.64% away from the 52-week low.\n\nWhat was the 52-week high for Molina Healthcare stock?\n\nThe high in the last 52 weeks of Molina Healthcare stock was 359.79. According to the current price, Molina Healthcare is 39.28% away from the 52-week high.\n\nWhat are analysts forecasts for Molina Healthcare stock?\n\nThe 55 analysts offering price forecasts for Molina Healthcare have a median target of 285.16, with a high estimate of 440.00 and a low estimate of 124.00. The median estimate represents a 49.56 difference from the last price of 141.32.\n\n## Molina Healthcare Stock Snapshot\n134\\.40\n\nBid\n\n100\\.00\n\nBid Size\n\n148\\.73\n\nAsk\n\n100\\.00\n\nAsk Size\n\n3\/10\/2026\n\nDate\n\n3:59 PM\n\nTime\n\n67,913.00\n\nVolume\n\n146\\.05\n\nPrev. Close\n\n146\\.28\n\nOpen\n\n7\\.52 B\n\nMarket Cap in USD\n\n51\\.50 M\n\nNumber of Shares\n\n51\\.50 M\n\nTotal Number of Shares\n\n137\\.78\n\nDay Low\n\n146\\.28\n\nDay High\n\n141\\.32\n\n121\\.16\n\n52 Week Low\n\n359\\.79\n\n52 Week High\n\n141\\.32\n\n0\\.00\n\nDividend in USD\n\n0\\.00\n\nDividend Yield\n\n19\\.45\n\nP\/E Ratio\n\n98\\.54\n\nFree Float in %\n\n8\\.92\n\nEPS in USD\n\n79\\.78\n\nBook Value per Share in USD\n\n\\-10.11\n\nCash Flow per Share in USD\n\n## Molina Healthcare News [More News](https:\/\/markets.businessinsider.com\/news\/moh-stock)\nTipRanks\n\n4d\n### [S\\&P 500 Rebalancing: Who’s In, Who’s Out?](https:\/\/markets.businessinsider.com\/news\/stocks\/s-p-500-rebalancing-who-s-in-who-s-out-1035907438)\n\nTipRanks\n\n4d\n### [S\\&P 600 adding fifteen companies at open on 3\/23](https:\/\/markets.businessinsider.com\/news\/stocks\/s-p-600-adding-fifteen-companies-at-open-on-3-23-1035907434)\n\nTipRanks\n\n4d\n### [Vertiv, Lumentum, Coherent, EchoStar set to join S\\&P 500 at open on 3\/23](https:\/\/markets.businessinsider.com\/news\/stocks\/vertiv-lumentum-coherent-echostar-set-to-join-s-p-500-at-open-on-3-23-1035907427)\n\nTipRanks\n\n6d\n### [Molina Healthcare price target lowered to \\$128 from \\$158 at Morgan Stanley](https:\/\/markets.businessinsider.com\/news\/stocks\/molina-healthcare-price-target-lowered-to-128-from-158-at-morgan-stanley-1035897240)\n\nTipRanks\n\n6d\n### [Centene price target raised to \\$45 from \\$38 at Morgan Stanley](https:\/\/markets.businessinsider.com\/news\/stocks\/centene-price-target-raised-to-45-from-38-at-morgan-stanley-1035897159)\n\n## Historical Prices for Molina Healthcare\nFeb. 10 2026❮ ❯\n\nMar. 10 2026❮ ❯\n\nDownload\n\nReset\n\n| Date ▼ | Open | Close | Daily High | Daily Low | Volume |\n|---|---|---|---|---|---|\n| 03\/06\/26 | 148\\.04 | 144\\.47 | 149\\.11 | 144\\.47 | 67,537.00 |\n| 03\/05\/26 | 148\\.80 | 147\\.74 | 150\\.81 | 145\\.52 | 24,193.00 |\n| 03\/04\/26 | 144\\.30 | 150\\.03 | 151\\.33 | 144\\.07 | 35,469.00 |\n| 03\/03\/26 | 149\\.21 | 144\\.83 | 149\\.47 | 142\\.53 | 56,868.00 |\n| 03\/02\/26 | 150\\.80 | 152\\.31 | 152\\.53 | 148\\.72 | 39,570.00 |\n| 02\/27\/26 | 147\\.55 | 154\\.13 | 154\\.90 | 145\\.98 | 82,716.00 |\n| 02\/26\/26 | 146\\.00 | 146\\.21 | 148\\.69 | 143\\.91 | 41,520.00 |\n| 02\/25\/26 | 150\\.21 | 145\\.59 | 153\\.12 | 145\\.11 | 55,482.00 |\n| 02\/24\/26 | 157\\.64 | 148\\.44 | 158\\.00 | 146\\.82 | 67,400.00 |\n| 02\/23\/26 | 150\\.86 | 156\\.22 | 156\\.93 | 150\\.51 | 52,267.00 |\n| 02\/20\/26 | 147\\.10 | 151\\.10 | 151\\.10 | 142\\.64 | 67,874.00 |\n| 02\/19\/26 | 144\\.89 | 148\\.24 | 148\\.49 | 140\\.99 | 47,946.00 |\n| 02\/18\/26 | 135\\.73 | 142\\.61 | 143\\.04 | 134\\.19 | 74,200.00 |\n| 02\/17\/26 | 135\\.07 | 135\\.68 | 137\\.17 | 133\\.18 | 60,150.00 |\n| 02\/13\/26 | 129\\.32 | 135\\.37 | 135\\.38 | 129\\.32 | 51,475.00 |\n| 02\/12\/26 | 123\\.01 | 126\\.76 | 128\\.74 | 122\\.95 | 52,771.00 |\n| 02\/11\/26 | 125\\.25 | 122\\.56 | 125\\.84 | 121\\.16 | 98,630.00 |\n| 02\/10\/26 | 128\\.44 | 125\\.34 | 129\\.01 | 125\\.34 | 90,708.00 |\n\nPrice change over selected period: 15\\.26%\\+19.13\n\n## Molina Healthcare Analyst Data\nTotal Analysts: 55\n\nBuy Ratings: 17   Neutral Ratings: 33   Sell Ratings: 5\n\nsavecancel\n\n(right-click to deleteright-click to manage)(long-press to drag)\n\nPrice\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 440  \n Rating: neutral\n\nAnalyst: Bank of America Merrill Lynch  \n Price-Target: 439  \n Rating: sell\n\nAnalyst: Bank of America Merrill Lynch  \n Price-Target: 439  \n Rating: sell\n\nAnalyst: Cantor Fitzgerald  \n Price-Target: 406  \n Rating: buy\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 410  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 430  \n Rating: neutral\n\nAnalyst: Stephens Inc.  \n Price-Target: 390  \n Rating: neutral\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 375  \n Rating: neutral\n\nAnalyst: Baird Patrick & Co  \n Price-Target: 405  \n Rating: buy\n\nAnalyst: J.P. Morgan  \n Price-Target: 420  \n Rating: buy\n\nAnalyst: J.P. Morgan  \n Price-Target: 395  \n Rating: buy\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 315  \n Rating: neutral\n\nAnalyst: Cantor Fitzgerald  \n Price-Target: 406  \n Rating: buy\n\nAnalyst: Jefferies & Company Inc.  \n Price-Target: 297  \n Rating: neutral\n\nAnalyst: Stephens Inc.  \n Price-Target: 320  \n Rating: neutral\n\nAnalyst: Deutsche Bank  \n Price-Target: 353  \n Rating: neutral\n\nAnalyst: Stephens Inc.  \n Price-Target: 345  \n Rating: neutral\n\nAnalyst: UBS  \n Price-Target: 325  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 339  \n Rating: neutral\n\nAnalyst: Mizuho  \n Price-Target: 376  \n Rating: buy\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 372  \n Rating: buy\n\nAnalyst: Mizuho  \n Price-Target: 400  \n Rating: buy\n\nAnalyst: Baird Patrick & Co  \n Price-Target: 375  \n Rating: neutral\n\nAnalyst: Bernstein  \n Price-Target: 414  \n Rating: buy\n\nAnalyst: Barclays Capital  \n Price-Target: 362  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 351  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 347  \n Rating: neutral\n\nAnalyst: Morgan Stanley  \n Price-Target: 364  \n Rating: buy\n\nAnalyst: Morgan Stanley  \n Price-Target: 266  \n Rating: neutral\n\nAnalyst: Mizuho  \n Price-Target: 330  \n Rating: buy\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 216  \n Rating: buy\n\nAnalyst: Baird Patrick & Co  \n Price-Target: 179  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 186  \n Rating: neutral\n\nAnalyst: Cantor Fitzgerald  \n Price-Target: 210  \n Rating: neutral\n\nAnalyst: UBS  \n Price-Target: 180  \n Rating: neutral\n\nAnalyst: J.P. Morgan  \n Price-Target: 184  \n Rating: neutral\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 198  \n Rating: buy\n\nAnalyst: Cantor Fitzgerald  \n Price-Target: 210  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 185  \n Rating: neutral\n\nAnalyst: Bernstein  \n Price-Target: 220  \n Rating: buy\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 231  \n Rating: buy\n\nAnalyst: Morgan Stanley  \n Price-Target: 204  \n Rating: neutral\n\nAnalyst: Goldman Sachs  \n Price-Target: 207  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 144  \n Rating: sell\n\nAnalyst: UBS  \n Price-Target: 170  \n Rating: neutral\n\nAnalyst: Cantor Fitzgerald  \n Price-Target: 180  \n Rating: neutral\n\nAnalyst: Goldman Sachs  \n Price-Target: 167  \n Rating: neutral\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 165  \n Rating: buy\n\nAnalyst: Barclays Capital  \n Price-Target: 164  \n Rating: sell\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 208  \n Rating: buy\n\nAnalyst: Cantor Fitzgerald  \n Price-Target: 144  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 133  \n Rating: sell\n\nAnalyst: Goldman Sachs  \n Price-Target: 124  \n Rating: neutral\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 141  \n Rating: neutral\n\nAnalyst: Morgan Stanley  \n Price-Target: 128  \n Rating: neutral\n\nAnalyst: {{ANALYST\\_DATA}}  \n Price-Target: {{PRICE\\_DATA}}  \n Rating: {{RATING\\_DATA}}\n\nPrice \\*Price Target\n\nLowest: 124\\.00   Median: 285\\.16   Highest: 440\\.00\n\n\\*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.\n\n## Molina Healthcare Analyst Opinions\nAll\n\n- All\n- Buy\n- Hold\n- Sell\n\n| Date |   | Analyst |   | Rating | Price |   |\n|---|---|---|---|---|---|---|\n| 03\/04\/26 |   | Morgan Stanley |   | Maintained Hold | \\$128 | neutral |\n| 02\/20\/26 |   | Wells Fargo & Co |   | Downgraded to Hold | \\$141 | neutral |\n| 02\/12\/26 |   | Goldman Sachs |   | Maintained Hold | \\$124 | neutral |\n| 02\/10\/26 |   | Barclays Capital |   | Maintained Sell | \\$133 | schlecht |\n| 02\/09\/26 |   | Cantor Fitzgerald |   | Maintained Hold | \\$144 | neutral |\n| 01\/07\/26 |   | Wells Fargo & Co |   | Maintained Buy | \\$208 | gut |\n| 01\/05\/26 |   | Barclays Capital |   | Maintained Sell | \\$164 | schlecht |\n| 11\/12\/25 |   | Wells Fargo & Co |   | Maintained Buy | \\$165 | gut |\n| 10\/24\/25 |   | Goldman Sachs |   | Maintained Hold | \\$167 | neutral |\n| 10\/24\/25 |   | UBS |   | Maintained Hold | \\$170 | neutral |\n| 10\/24\/25 |   | Cantor Fitzgerald |   | Maintained Hold | \\$180 | neutral |\n| 10\/24\/25 |   | Barclays Capital |   | Downgraded to Sell | \\$144 | schlecht |\n| 10\/14\/25 |   | Morgan Stanley |   | Maintained Hold | \\$204 | neutral |\n| 10\/14\/25 |   | Goldman Sachs |   | Maintained Hold | \\$207 | neutral |\n| 10\/07\/25 |   | Wells Fargo & Co |   | Maintained Buy | \\$231 | gut |\n| 09\/05\/25 |   | Bernstein |   | Maintained Buy | \\$220 | gut |\n| 09\/04\/25 |   | Barclays Capital |   | Maintained Hold | \\$185 | neutral |\n| 08\/26\/25 |   | Cantor Fitzgerald |   | Maintained Hold | \\$210 | neutral |\n| 08\/15\/25 |   | Wells Fargo & Co |   | Maintained Buy | \\$198 | gut |\n| 07\/29\/25 |   | J.P. Morgan |   | Maintained Hold | \\$184 | neutral |\n| 07\/25\/25 |   | UBS |   | Maintained Hold | \\$180 | neutral |\n| 07\/25\/25 |   | Barclays Capital |   | Maintained Hold | \\$186 | neutral |\n| 07\/25\/25 |   | Cantor Fitzgerald |   | Downgraded to Hold | \\$210 | neutral |\n| 07\/25\/25 |   | Baird Patrick & Co |   | Maintained Hold | \\$179 | neutral |\n| 07\/23\/25 |   | Wells Fargo & Co |   | Maintained Buy | \\$216 | gut |\n| 07\/11\/25 |   | Mizuho |   | Maintained Buy | \\$330 | gut |\n| 07\/10\/25 |   | Morgan Stanley |   | Downgraded to Hold | \\$266 | neutral |\n| 06\/09\/25 |   | Barclays Capital |   | Maintained Hold | \\$347 | neutral |\n| 06\/09\/25 |   | Morgan Stanley |   | Maintained Buy | \\$364 | gut |\n| 06\/02\/25 |   | Barclays Capital |   | Maintained Hold | \\$351 | neutral |\n| 04\/25\/25 |   | Barclays Capital |   | Maintained Hold | \\$362 | neutral |\n| 04\/22\/25 |   | Bernstein |   | Maintained Buy | \\$414 | gut |\n| 04\/15\/25 |   | Baird Patrick & Co |   | Downgraded to Hold | \\$375 | neutral |\n| 04\/09\/25 |   | Guggenheim |   | Maintained Hold |   | neutral |\n| 04\/09\/25 |   | Mizuho |   | Maintained Buy | \\$400 | gut |\n| 03\/05\/25 |   | Wells Fargo & Co |   | Upgraded to Buy | \\$372 | gut |\n| 03\/03\/25 |   | Mizuho |   | Maintained Buy | \\$376 | gut |\n| 02\/07\/25 |   | Barclays Capital |   | Maintained Hold | \\$339 | neutral |\n| 02\/07\/25 |   | UBS |   | Maintained Hold | \\$325 | neutral |\n| 02\/06\/25 |   | Stephens Inc. |   | Maintained Hold | \\$345 | neutral |\n| 07\/29\/24 |   | Deutsche Bank |   | Maintained Hold | \\$353 | neutral |\n| 07\/25\/24 |   | Stephens Inc. |   | Maintained Hold | \\$320 | neutral |\n| 07\/24\/24 |   | Jefferies & Company Inc. |   | Maintained Hold | \\$297 | neutral |\n| 07\/23\/24 |   | Cantor Fitzgerald |   | Maintained Buy | \\$406 | gut |\n| 07\/22\/24 |   | Wells Fargo & Co |   | Maintained Hold | \\$315 | neutral |\n| 07\/10\/24 |   | J.P. Morgan |   | Maintained Buy | \\$395 | gut |\n| 05\/30\/24 |   | J.P. Morgan |   | Maintained Buy | \\$420 | gut |\n| 05\/30\/24 |   | Baird Patrick & Co |   | Maintained Buy | \\$405 | gut |\n| 04\/29\/24 |   | Wells Fargo & Co |   | Maintained Hold | \\$375 | neutral |\n| 04\/25\/24 |   | Barclays Capital |   | Maintained Hold | \\$430 | neutral |\n\n## Molina Healthcare Estimates\\* in USD\n- Yearly\n- Quarterly\n\n|   | 2026 | 2027 | 2028 | 2029 | 2030 |\n|---|---|---|---|---|---|\n| Revenue | 45,193 | 48,090 | 50,280 | \\- | \\- |\n| Dividend | 0\\.00 | 0\\.00 | 0\\.00 | \\- | \\- |\n| Dividend Yield (in %) | 0\\.00 % | 0\\.00 % | 0\\.00 % | \\- | \\- |\n| EPS | 6\\.16 | 10\\.40 | 16\\.54 | 30\\.50 | \\- |\n| P\/E Ratio | 23\\.72 | 14\\.04 | 8\\.83 | 4\\.79 | 5\\.71 |\n| EBIT | 667 | 831 | 1,180 | 1,981 | \\- |\n| EBITDA | 791 | 910 | 1,087 | \\- | \\- |\n| Net Profit | 390 | 510 | 799 | 1,378 | \\- |\n| Net Profit Adjusted | 390 | 510 | 799 | 1,378 | \\- |\n| Pre-Tax Profit | 466 | 662 | 1,054 | 1,795 | \\- |\n| Pre-Tax Profit Reported | 242 | 405 | \\- | \\- | \\- |\n| EPS (Non-GAAP) ex. SOE | 10\\.15 | 13\\.32 | 12\\.29 | \\- | \\- |\n| EPS (GAAP) | 5\\.80 | 9\\.47 | 16\\.38 | \\- | \\- |\n| Gross Income | \\- | \\- | \\- | \\- | \\- |\n| Cash Flow from Investing | \\-328 | \\-284 | \\-203 | \\- | \\- |\n| Cash Flow from Operations | 552 | 732 | 865 | \\- | \\- |\n| Cash Flow from Financing | \\-285 | \\-281 | \\-68 | \\- | \\- |\n| Cash Flow per Share | 5\\.47 | 13\\.12 | 17\\.29 | \\- | \\- |\n| Free Cash Flow | 509 | 788 | 1,040 | \\- | \\- |\n| Free Cash Flow per Share | \\- | \\- | \\- | \\- | \\- |\n| Book Value per Share | 90\\.68 | 107\\.16 | 139\\.93 | \\- | \\- |\n| Net Debt | \\-1,638 | \\-2,220 | \\-3,290 | \\- | \\- |\n| Research & Development Exp. | \\- | \\- | \\- | \\- | \\- |\n| Capital Expenditure | 128 | 140 | 173 | \\- | \\- |\n| Selling, General & Admin. Exp. | 3,486 | 3,703 | 3,044 | \\- | \\- |\n| Shareholder’s Equity | 4,276 | 4,621 | 5,030 | \\- | \\- |\n| Total Assets | 15,534 | 15,974 | 16,659 | \\- | \\- |\n\n|   | Previous Quarter   ending 12\/31\/25 | Current Quarter   ending 03\/31\/26 | Next Quarter   ending 06\/30\/26 | Current Year   ending 12\/31\/26 | Next Year   ending 12\/31\/27 |\n|---|---|---|---|---|---|\n| Earnings Estimates |   |   |   |   |   |\n| No. of Analysts | \\- | 17 | 17 | 17 | 18 |\n| Average Estimate | \\- | 2\\.601 USD | 2\\.098 USD | 6\\.617 USD | 10\\.399 USD |\n| Year Ago | \\- | 5\\.458 USD | 4\\.758 USD | 8\\.939 USD | \\- |\n| Publish Date | \\- | 4\/22\/2026 | 7\/29\/2026 | \\- | \\- |\n| Revenue Estimates |   |   |   |   |   |\n| No. of Analysts | \\- | 11 | 11 | 16 | 14 |\n| Average Estimate | \\- | 11,016 USD | 11,091 USD | 45,193 USD | 48,090 USD |\n| Year Ago | \\- | 11,147 USD | 11,427 USD | 45,426 USD | \\- |\n| Publish Date | \\- | 4\/22\/2026 | 7\/29\/2026 | \\- | \\- |\n\n\\* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet\n\n## Income Statements in Mio. USD\n|   | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |\n|---|---|---|---|---|---|---|---|\n| Sales | 45,426.00 | 40,650.00 | 34,072.00 | 31,974.00 | 27,771.00 | 19,295.00 | 16,829.00 |\n| Change of sales in % | 11\\.75 | 19\\.31 | 6\\.56 | 15\\.13 | 43\\.93 | 14\\.65 | \\-10.91 |\n| Gross profit on sales | \\- | \\- | \\- | \\- | \\- | \\- | \\- |\n| Gross profit on sales change in % | \\- | \\- | \\- | \\- | \\- | \\- | \\- |\n| Operating income | 781\\.00 | 1,707.00 | 1,573.00 | 1,381.00 | 1,020.00 | 950\\.00 | 1,050.00 |\n| Operating income change in % | \\-54.25 | 8\\.52 | 13\\.90 | 35\\.39 | 7\\.37 | \\-9.52 | \\-11.91 |\n| Income before tax | 589\\.00 | 1,589.00 | 1,464.00 | 1,063.00 | 875\\.00 | 961\\.00 | 972\\.00 |\n| Income before tax change in % | \\-62.93 | 8\\.54 | 37\\.72 | 21\\.49 | \\-8.95 | \\-1.13 | \\-2.70 |\n| Income after tax | 472\\.00 | 1,179.00 | 1,091.00 | 792\\.00 | 659\\.00 | 673\\.00 | 737\\.00 |\n| Income after tax change in % | \\-59.97 | 8\\.07 | 37\\.75 | 20\\.18 | \\-2.08 | \\-8.68 | 4\\.24 |\n\n## Balance Sheet in Mio. USD\n|   | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |\n|---|---|---|---|---|---|---|---|\n| Total liabilities | 11,541.00 | 11,186.00 | 10,720.00 | 9,365.00 | 9,593.00 | 7,465.00 | 4,836.00 |\n| Long-term liabilities per share | \\- | \\- | \\- | \\- | \\- | \\- | \\- |\n| Equity | 4,069.00 | 4,496.00 | 4,215.00 | 2,964.00 | 2,630.00 | 2,096.00 | 1,960.00 |\n| Equity change in % | \\-9.50 | 6\\.67 | 42\\.21 | 12\\.70 | 25\\.48 | 6\\.94 | 19\\.00 |\n| Balance sheet total | 15,610.00 | 15,682.00 | 14,935.00 | 12,329.00 | 12,223.00 | 9,561.00 | 6,796.00 |\n| Balance sheet total change in % | \\-0.46 | 5\\.00 | 21\\.14 | 0\\.87 | 27\\.84 | 40\\.69 | \\-5.08 |\n\n## Key Data in USD\n|   | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |\n|---|---|---|---|---|---|---|---|\n| Sales per share | 858\\.71 | 704\\.51 | 586\\.44 | 546\\.56 | 473\\.91 | 322\\.12 | 262\\.13 |\n| P\/E ratio (year end quote, basic EPS) | 19\\.45 | 14\\.24 | 19\\.24 | 24\\.39 | 28\\.28 | 18\\.93 | 11\\.82 |\n| P\/E ratio (year end quote, diluted EPS) | 19\\.45 | 14\\.24 | 19\\.24 | 24\\.39 | 28\\.28 | 18\\.93 | 11\\.82 |\n| Dividend yield in % | 0\\.00 | 0\\.00 | 0\\.00 | 0\\.00 | 0\\.00 | 0\\.00 | 0\\.00 |\n| Equity ratio in % | 26\\.07 | 28\\.67 | 28\\.22 | 24\\.04 | 21\\.52 | 21\\.92 | 28\\.84 |\n| Debt ratio in % | 73\\.93 | 71\\.33 | 71\\.78 | 75\\.96 | 78\\.48 | 78\\.08 | 71\\.16 |\n\n## Molina Healthcare Insider Activity\n| Name | Date | shares traded | shares held | Price | type (sell\/buy) | option |\n|---|---|---|---|---|---|---|\n| [ZORETIC RICHARD C](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/zoretic-richard-c-596591) | 02\/10\/2026 | 800\\.00 | 8,747.00 | 125\\.16 | Buy | No |\n| [ZORETIC RICHARD C](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/zoretic-richard-c-596591) | 12\/31\/2025 | 317\\.00 | 7,947.00 | 173\\.54 | Buy | No |\n| [Lockhart Stephen H](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/lockhart-stephen-h-1158854) | 12\/31\/2025 | 317\\.00 | 3,742.00 | 173\\.54 | Buy | No |\n| [ROMNEY RONNA](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/romney-ronna-415986) | 12\/31\/2025 | 317\\.00 | 17,733.00 | 173\\.54 | Buy | No |\n| [ORLANDO STEVEN J](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/orlando-steven-j-389156) | 12\/31\/2025 | 317\\.00 | 17,325.00 | 173\\.54 | Buy | No |\n| [Bacon Debra](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/bacon-debra-1285131) | 12\/30\/2025 | 22\\.00 | 12,906.00 | 147\\.51 | Buy | No |\n| [Schapiro Richard M](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/schapiro-richard-m-972253) | 11\/23\/2025 | 357\\.00 | 11,352.00 | 143\\.02 | Sell | No |\n| [ROMNEY RONNA](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/romney-ronna-415986) | 09\/30\/2025 | 285\\.00 | 17,416.00 | 192\\.79 | Buy | No |\n| [ROMNEY RONNA](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/romney-ronna-415986) | 08\/05\/2025 | 700\\.00 | 17,131.00 | 153\\.74 | Sell | No |\n| [WOYS JAMES](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/woys-james-400394) | 08\/03\/2025 | 5,500.00 | 69,831.00 | 155\\.59 | Buy | No |\n| [WOYS JAMES](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/woys-james-400394) | 08\/03\/2025 | 4,500.00 | 74,331.00 | 156\\.36 | Buy | No |\n| [Bacon Debra](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/bacon-debra-1285131) | 06\/30\/2025 | 183\\.00 | 12,884.00 | 306\\.29 | Sell | No |\n| [WOLF DALE B](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/wolf-dale-b-417517) | 06\/30\/2025 | 180\\.00 | 14,389.00 | 306\\.29 | Buy | No |\n| [ORLANDO STEVEN J](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/orlando-steven-j-389156) | 06\/30\/2025 | 180\\.00 | 16,723.00 | 306\\.29 | Buy | No |\n| [Schapiro Richard M](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/schapiro-richard-m-972253) | 06\/30\/2025 | 180\\.00 | 11,424.00 | 306\\.29 | Buy | No |\n| [Bacon Debra](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/bacon-debra-1285131) | 06\/29\/2025 | 41\\.00 | 13,067.00 | 247\\.39 | Buy | No |\n| [Barlow Jeff D.](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/barlow-jeff-d.-887526) | 06\/29\/2025 | 85\\.00 | 72,902.00 | 247\\.39 | Buy | No |\n| [WOLF DALE B](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/wolf-dale-b-417517) | 05\/20\/2025 | 100\\.00 | 14,209.00 | 324\\.42 | Sell | No |\n| [WOLF DALE B](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/wolf-dale-b-417517) | 05\/20\/2025 | 900\\.00 | 14,309.00 | 323\\.27 | Sell | No |\n| [WOLF DALE B](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/wolf-dale-b-417517) | 05\/20\/2025 | 400\\.00 | 15,209.00 | 322\\.23 | Sell | No |\n| [WOLF DALE B](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/wolf-dale-b-417517) | 05\/20\/2025 | 100\\.00 | 15,609.00 | 320\\.51 | Sell | No |\n| [GROHOWSKI LEO P](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/grohowski-leo-p-422931) | 04\/30\/2025 | 118\\.00 | 118\\.00 | 313\\.04 | Buy | No |\n| [Zubretsky Joseph M](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/zubretsky-joseph-m-667743) | 04\/29\/2025 | 86,400.00 | 258,815.00 | 320\\.00 | Sell | No |\n| [Zubretsky Joseph M](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/zubretsky-joseph-m-667743) | 04\/29\/2025 | 1,100.00 | 257,715.00 | 324\\.70 | Sell | No |\n| [Schapiro Richard M](https:\/\/markets.businessinsider.com\/stocks\/insideractivitytrader\/schapiro-richard-m-972253) | 04\/28\/2025 | 669\\.00 | 11,244.00 | 320\\.50 | Sell | No |\n\n## Molina Healthcare Dividend Calendar\n| Date | Name | Dividend | \\*yield | Currency |\n|---|---|---|---|---|\n| 2025 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2024 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2023 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2022 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2021 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2020 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2019 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2018 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2017 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2016 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2015 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2014 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2013 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2012 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2011 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2010 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2009 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n| 2008 | Molina Healthcare | 0\\.00 | 0\\.00 | USD |\n\n\\*Yield of the Respective Date\n\n## Molina Healthcare Calendar\n| Event | Estimate | Info | Date |\n|---|---|---|---|\n| Earnings Report | 2\\.524 USD | Q1 2026 Earnings Release | 04\/22\/2026 |\n| Earnings Report | 1\\.976 USD | Q2 2026 Earnings Release | 07\/29\/2026 |\n| Earnings Report | 1\\.321 USD | Q3 2026 Earnings Release | 10\/28\/2026 |\n| Earnings Report | 0\\.321 USD | Q4 2026 Earnings Release | 02\/10\/2027 |\n| Earnings Report | 3\\.174 USD | Q1 2027 Earnings Release | 04\/28\/2027 |\n\n## Molina Healthcare Past Events\n| Event | Actual EPS | Info | Date |\n|---|---|---|---|\n| Earnings Report | \\-3.150 USD | Q4 2025 Earnings Release | 02\/05\/2026 |\n| Earnings Report | 1\\.510 USD | Q3 2025 Earnings Release | 10\/22\/2025 |\n| Earnings Report | 4\\.750 USD | Q2 2025 Earnings Release | 07\/23\/2025 |\n| Annual General Meeting | 20\\.420 USD | Annual General Meeting | 04\/30\/2025 |\n| Earnings Report | 5\\.450 USD | Q1 2025 Earnings Release | 04\/23\/2025 |\n| Earnings Report | 4\\.440 USD | Q4 2024 Earnings Release | 02\/05\/2025 |\n| Earnings Report | 5\\.650 USD | Q3 2024 Earnings Release | 10\/23\/2024 |\n| Earnings Report | 5\\.170 USD | Q2 2024 Earnings Release | 07\/24\/2024 |\n| Annual General Meeting | 18\\.770 USD | Annual General Meeting | 05\/01\/2024 |\n| Earnings Report | 5\\.170 USD | Q1 2024 Earnings Release | 04\/24\/2024 |\n| Earnings Report | 3\\.700 USD | Q4 2023 Earnings Release | 02\/07\/2024 |\n| Earnings Report | 4\\.210 USD | Q3 2023 Earnings Release | 10\/25\/2023 |\n| Earnings Report | 5\\.350 USD | Q2 2023 Earnings Release | 07\/26\/2023 |\n| Annual General Meeting | 13\\.550 USD | Annual General Meeting | 05\/03\/2023 |\n| Earnings Report | 5\\.520 USD | Q1 2023 Earnings Release | 04\/26\/2023 |\n| Earnings Report | 0\\.960 USD | Q4 2022 Earnings Release | 02\/08\/2023 |\n| Earnings Report | 3\\.950 USD | Q3 2022 Earnings Release | 10\/26\/2022 |\n| Earnings Report | 4\\.250 USD | Q2 2022 Earnings Release | 07\/27\/2022 |\n| Annual General Meeting | 11\\.250 USD | Annual General Meeting | 05\/04\/2022 |\n| Earnings Report | 4\\.390 USD | Q1 2022 Earnings Release | 04\/27\/2022 |\n| Earnings Report | 1\\.740 USD | Q4 2021 Earnings Release | 02\/09\/2022 |\n\n## Molina Healthcare Profile\nMolina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.\n\n## Moody’s Daily Credit Risk Score\nRisk\n\n- Low\n- Medium\n- High\n\n4\n\nMoody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.\n\n## Molina Healthcare Management\n| Name | Job |\n|---|---|\n| Maurice S. Hebert | Chief Accounting Officer |\n| Mark L. Keim | Chief Financial Officer & Senior Executive VP |\n| Lawrence D. Anderson | Chief Human Resources Officer |\n| Carolyn Ingram | Chief Marketing Officer |\n| Jason Dees | Chief Medical Officer |\n| James E. Woys | Chief Operating Officer |\n| Ronald M. Kurtz | Chief of Staff |\n| Leo P. Grohowski | Director |\n| Debra J. Bacon | Executive Vice President-Medicaid |\n| Richard C. Zoretic | Independent Director |\n| Richard M. Schapiro | Independent Director |\n| Barbara L. Brasier | Independent Director |\n| Stephen H. Lockhart | Independent Director |\n| Steven J. Orlando | Independent Director |\n| Dale B. Wolf | Non-Executive Chairman |\n| Joseph M. Zubretsky | President, Chief Executive Officer & Director |\n| Jeff D. Barlow | Secretary & Chief Legal Officer |\n| Steve O'Dell | Senior VP-Growth & Corporate Development |\n| Ronna E. Romney | Vice Chairman |\n| Jeffrey Geyer | Vice President-Investor Relations |\n\n[![Click to visit Markets Insider](https:\/\/markets.businessinsider.com\/public\/assets\/MI\/logos\/markets-insider-stacked.svg) ![](https:\/\/markets.businessinsider.com\/public\/assets\/MI\/logos\/markets-insider-stacked.svg)](https:\/\/markets.businessinsider.com\/)\n\n[![Facebook](https:\/\/markets.businessinsider.com\/public\/assets\/social\/social-facebook.svg) ![](https:\/\/markets.businessinsider.com\/public\/assets\/social\/social-facebook.svg)](https:\/\/www.facebook.com\/MrktsInsider \"Follow us on Facebook\")\n\n[![X](https:\/\/markets.businessinsider.com\/public\/assets\/social\/social-x.svg) ![](https:\/\/markets.businessinsider.com\/public\/assets\/social\/social-x.svg)](https:\/\/x.com\/mktsinsider \"Follow us on X\")\n***\n[Indices](https:\/\/markets.businessinsider.com\/indices) [Dow Jones](https:\/\/markets.businessinsider.com\/index\/dow_jones) [S\\&P 500](https:\/\/markets.businessinsider.com\/index\/s&p_500) [Nasdaq 100](https:\/\/markets.businessinsider.com\/index\/nasdaq_100) [Nasdaq Composite](https:\/\/markets.businessinsider.com\/index\/nasdaq_composite) [FTSE 100](https:\/\/markets.businessinsider.com\/index\/ftse_100) [Nikkei 225](https:\/\/markets.businessinsider.com\/index\/nikkei_225) [DAX 40](https:\/\/markets.businessinsider.com\/index\/dax) [Hang Seng](https:\/\/markets.businessinsider.com\/index\/hang_seng) [Kospi](https:\/\/markets.businessinsider.com\/index\/kospi) [S\\&P TSX Composite Index](https:\/\/markets.businessinsider.com\/index\/s&p_tsx_composite_index) [ASX](https:\/\/markets.businessinsider.com\/index\/asx) [US Dollar Index](https:\/\/markets.businessinsider.com\/index\/us-dollar-index) [Stock Indices](https:\/\/markets.businessinsider.com\/indices) [Dow Futures](https:\/\/markets.businessinsider.com\/futures\/dow-futures) [Dow Jones Market Movers](https:\/\/markets.businessinsider.com\/market-movers\/dow_jones)\n\n[Commodities](https:\/\/markets.businessinsider.com\/commodities) [Gold Price](https:\/\/markets.businessinsider.com\/commodities\/gold-price) [Oil Price](https:\/\/markets.businessinsider.com\/commodities\/oil-price?type=wti) [Silver Price](https:\/\/markets.businessinsider.com\/commodities\/silver-price) [Copper Price](https:\/\/markets.businessinsider.com\/commodities\/copper-price) [Cotton Price](https:\/\/markets.businessinsider.com\/commodities\/cotton-price) [Heating Oil Price](https:\/\/markets.businessinsider.com\/commodities\/heating-oil-price) [Aluminum Price](https:\/\/markets.businessinsider.com\/commodities\/aluminum-price) [Natural Gas Price](https:\/\/markets.businessinsider.com\/commodities\/natural-gas-price) [Realtime Commodity Prices](https:\/\/markets.businessinsider.com\/commodities\/realtime-list)\n\n[Currencies](https:\/\/markets.businessinsider.com\/currencies) [EURO DOLLAR](https:\/\/markets.businessinsider.com\/currencies\/eur-usd) [Bitcoin Price](https:\/\/markets.businessinsider.com\/currencies\/btc-usd) [ETH USD](https:\/\/markets.businessinsider.com\/currencies\/eth-usd) [CAD USD](https:\/\/markets.businessinsider.com\/currencies\/usd-cad) [PESO USD](https:\/\/markets.businessinsider.com\/currencies\/usd-mxn) [POUND USD](https:\/\/markets.businessinsider.com\/currencies\/gbp-usd) [USD INR](https:\/\/markets.businessinsider.com\/currencies\/usd-inr) [Currency Converter](https:\/\/markets.businessinsider.com\/currency-converter) [Exchange Rates](https:\/\/markets.businessinsider.com\/currencies)\n\n[Stocks](https:\/\/markets.businessinsider.com\/stocks) [Google Stock](https:\/\/markets.businessinsider.com\/stocks\/goog-stock) [Meta Stock](https:\/\/markets.businessinsider.com\/stocks\/meta-stock) [Amazon Stock](https:\/\/markets.businessinsider.com\/stocks\/amzn-stock) [Tesla Stock](https:\/\/markets.businessinsider.com\/stocks\/tsla-stock) [Dow-Stock](https:\/\/markets.businessinsider.com\/stocks\/dow-stock) [Premarket](https:\/\/markets.businessinsider.com\/premarket) [Stock Market News](https:\/\/markets.businessinsider.com\/news)\n\nSee more categories\n***\n[Copyright © 2026](https:\/\/businessinsider.com\/terms) Insider Inc and [finanzen.net](https:\/\/www.finanzen.net\/impressum) GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our [Terms of Service](https:\/\/www.businessinsider.com\/terms) and [Privacy Policy.](https:\/\/www.businessinsider.com\/privacy-policy)\n\n[Disclaimer](https:\/\/www.businessinsider.com\/disclaimer) [Accessibility](https:\/\/www.businessinsider.com\/accessibility) [Commerce Policy](https:\/\/www.businessinsider.com\/commerce-policy) [Advertising Policies](https:\/\/www.businessinsider.com\/advertising-policies) Stock quotes by [finanzen.net](https:\/\/www.finanzen.net\/) [Contact Us](https:\/\/www.businessinsider.com\/contact) [Masthead](https:\/\/www.businessinsider.com\/masthead)\n\nCookie Settings\n\n![Business Insider Logo](https:\/\/markets.businessinsider.com\/public\/assets\/logos\/stacked-black.svg)\n\n![](https:\/\/markets.businessinsider.com\/public\/assets\/logos\/stacked-black.svg)\n\n![Insider Logo](https:\/\/markets.businessinsider.com\/public\/assets\/INSIDER\/US\/logos\/Insider-logo-dark-opt.svg)\n\n![](https:\/\/markets.businessinsider.com\/public\/assets\/INSIDER\/US\/logos\/Insider-logo-dark-opt.svg)","attrs_readable_markdown":"Price\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 440  \n Rating: neutral\n\nAnalyst: Bank of America Merrill Lynch  \n Price-Target: 439  \n Rating: sell\n\nAnalyst: Bank of America Merrill Lynch  \n Price-Target: 439  \n Rating: sell\n\nAnalyst: Cantor Fitzgerald  \n Price-Target: 406  \n Rating: buy\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 410  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 430  \n Rating: neutral\n\nAnalyst: Stephens Inc.  \n Price-Target: 390  \n Rating: neutral\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 375  \n Rating: neutral\n\nAnalyst: Baird Patrick & Co  \n Price-Target: 405  \n Rating: buy\n\nAnalyst: J.P. Morgan  \n Price-Target: 420  \n Rating: buy\n\nAnalyst: J.P. Morgan  \n Price-Target: 395  \n Rating: buy\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 315  \n Rating: neutral\n\nAnalyst: Cantor Fitzgerald  \n Price-Target: 406  \n Rating: buy\n\nAnalyst: Jefferies & Company Inc.  \n Price-Target: 297  \n Rating: neutral\n\nAnalyst: Stephens Inc.  \n Price-Target: 320  \n Rating: neutral\n\nAnalyst: Deutsche Bank  \n Price-Target: 353  \n Rating: neutral\n\nAnalyst: Stephens Inc.  \n Price-Target: 345  \n Rating: neutral\n\nAnalyst: UBS  \n Price-Target: 325  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 339  \n Rating: neutral\n\nAnalyst: Mizuho  \n Price-Target: 376  \n Rating: buy\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 372  \n Rating: buy\n\nAnalyst: Mizuho  \n Price-Target: 400  \n Rating: buy\n\nAnalyst: Baird Patrick & Co  \n Price-Target: 375  \n Rating: neutral\n\nAnalyst: Bernstein  \n Price-Target: 414  \n Rating: buy\n\nAnalyst: Barclays Capital  \n Price-Target: 362  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 351  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 347  \n Rating: neutral\n\nAnalyst: Morgan Stanley  \n Price-Target: 364  \n Rating: buy\n\nAnalyst: Morgan Stanley  \n Price-Target: 266  \n Rating: neutral\n\nAnalyst: Mizuho  \n Price-Target: 330  \n Rating: buy\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 216  \n Rating: buy\n\nAnalyst: Baird Patrick & Co  \n Price-Target: 179  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 186  \n Rating: neutral\n\nAnalyst: Cantor Fitzgerald  \n Price-Target: 210  \n Rating: neutral\n\nAnalyst: UBS  \n Price-Target: 180  \n Rating: neutral\n\nAnalyst: J.P. Morgan  \n Price-Target: 184  \n Rating: neutral\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 198  \n Rating: buy\n\nAnalyst: Cantor Fitzgerald  \n Price-Target: 210  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 185  \n Rating: neutral\n\nAnalyst: Bernstein  \n Price-Target: 220  \n Rating: buy\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 231  \n Rating: buy\n\nAnalyst: Morgan Stanley  \n Price-Target: 204  \n Rating: neutral\n\nAnalyst: Goldman Sachs  \n Price-Target: 207  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 144  \n Rating: sell\n\nAnalyst: UBS  \n Price-Target: 170  \n Rating: neutral\n\nAnalyst: Cantor Fitzgerald  \n Price-Target: 180  \n Rating: neutral\n\nAnalyst: Goldman Sachs  \n Price-Target: 167  \n Rating: neutral\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 165  \n Rating: buy\n\nAnalyst: Barclays Capital  \n Price-Target: 164  \n Rating: sell\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 208  \n Rating: buy\n\nAnalyst: Cantor Fitzgerald  \n Price-Target: 144  \n Rating: neutral\n\nAnalyst: Barclays Capital  \n Price-Target: 133  \n Rating: sell\n\nAnalyst: Goldman Sachs  \n Price-Target: 124  \n Rating: neutral\n\nAnalyst: Wells Fargo & Co  \n Price-Target: 141  \n Rating: neutral\n\nAnalyst: Morgan Stanley  \n Price-Target: 128  \n Rating: neutral","meta_canonical":null}

3. Robots.txt Check

Query:

Response:

4. Spam/Ban Check

Query:

Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄

INDEXABLE

✅

CRAWLED

1 month ago

🤖

ROBOTS SERVER UNREACHABLE

Failed to connect to robots server: Operation timed out after 2002 milliseconds with 0 bytes received

Page Info Filters

Filter	Status	Condition	Details
HTTP status	PASS	`download_http_code = 200`	HTTP 200
Age cutoff	PASS	`download_stamp > now() - 6 MONTH`	1.1 months ago
History drop	PASS	`isNull(history_drop_reason)`	No drop reason
Spam/ban	PASS	`fh_dont_index != 1 AND ml_spam_score = 0`	ml_spam_score=0
Canonical	PASS	`meta_canonical IS NULL OR = '' OR = src_unparsed`	Not set

Page Details

Property	Value
URL	https://markets.businessinsider.com/stocks/moh-stock
Last Crawled	2026-03-11 00:39:00 (1 month ago)
First Indexed	2018-08-21 21:48:19 (7 years ago)
HTTP Status Code	200
Meta Title	Molina Healthcare Stock Price \| MOH Stock Quote, News, and History \| Markets Insider
Meta Description	The latest Molina Healthcare stock prices, stock quotes, news, and MOH history to help you invest and trade smarter.
Meta Canonical	null
Boilerpipe Text	Price Analyst: Wells Fargo & Co Price-Target: 440 Rating: neutral Analyst: Bank of America Merrill Lynch Price-Target: 439 Rating: sell Analyst: Bank of America Merrill Lynch Price-Target: 439 Rating: sell Analyst: Cantor Fitzgerald Price-Target: 406 Rating: buy Analyst: Wells Fargo & Co Price-Target: 410 Rating: neutral Analyst: Barclays Capital Price-Target: 430 Rating: neutral Analyst: Stephens Inc. Price-Target: 390 Rating: neutral Analyst: Wells Fargo & Co Price-Target: 375 Rating: neutral Analyst: Baird Patrick & Co Price-Target: 405 Rating: buy Analyst: J.P. Morgan Price-Target: 420 Rating: buy Analyst: J.P. Morgan Price-Target: 395 Rating: buy Analyst: Wells Fargo & Co Price-Target: 315 Rating: neutral Analyst: Cantor Fitzgerald Price-Target: 406 Rating: buy Analyst: Jefferies & Company Inc. Price-Target: 297 Rating: neutral Analyst: Stephens Inc. Price-Target: 320 Rating: neutral Analyst: Deutsche Bank Price-Target: 353 Rating: neutral Analyst: Stephens Inc. Price-Target: 345 Rating: neutral Analyst: UBS Price-Target: 325 Rating: neutral Analyst: Barclays Capital Price-Target: 339 Rating: neutral Analyst: Mizuho Price-Target: 376 Rating: buy Analyst: Wells Fargo & Co Price-Target: 372 Rating: buy Analyst: Mizuho Price-Target: 400 Rating: buy Analyst: Baird Patrick & Co Price-Target: 375 Rating: neutral Analyst: Bernstein Price-Target: 414 Rating: buy Analyst: Barclays Capital Price-Target: 362 Rating: neutral Analyst: Barclays Capital Price-Target: 351 Rating: neutral Analyst: Barclays Capital Price-Target: 347 Rating: neutral Analyst: Morgan Stanley Price-Target: 364 Rating: buy Analyst: Morgan Stanley Price-Target: 266 Rating: neutral Analyst: Mizuho Price-Target: 330 Rating: buy Analyst: Wells Fargo & Co Price-Target: 216 Rating: buy Analyst: Baird Patrick & Co Price-Target: 179 Rating: neutral Analyst: Barclays Capital Price-Target: 186 Rating: neutral Analyst: Cantor Fitzgerald Price-Target: 210 Rating: neutral Analyst: UBS Price-Target: 180 Rating: neutral Analyst: J.P. Morgan Price-Target: 184 Rating: neutral Analyst: Wells Fargo & Co Price-Target: 198 Rating: buy Analyst: Cantor Fitzgerald Price-Target: 210 Rating: neutral Analyst: Barclays Capital Price-Target: 185 Rating: neutral Analyst: Bernstein Price-Target: 220 Rating: buy Analyst: Wells Fargo & Co Price-Target: 231 Rating: buy Analyst: Morgan Stanley Price-Target: 204 Rating: neutral Analyst: Goldman Sachs Price-Target: 207 Rating: neutral Analyst: Barclays Capital Price-Target: 144 Rating: sell Analyst: UBS Price-Target: 170 Rating: neutral Analyst: Cantor Fitzgerald Price-Target: 180 Rating: neutral Analyst: Goldman Sachs Price-Target: 167 Rating: neutral Analyst: Wells Fargo & Co Price-Target: 165 Rating: buy Analyst: Barclays Capital Price-Target: 164 Rating: sell Analyst: Wells Fargo & Co Price-Target: 208 Rating: buy Analyst: Cantor Fitzgerald Price-Target: 144 Rating: neutral Analyst: Barclays Capital Price-Target: 133 Rating: sell Analyst: Goldman Sachs Price-Target: 124 Rating: neutral Analyst: Wells Fargo & Co Price-Target: 141 Rating: neutral Analyst: Morgan Stanley Price-Target: 128 Rating: neutral
Markdown	![](data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0iMS4wIiBlbmNvZGluZz0iVVRGLTgiPz48c3ZnIHdpZHRoPSI5OTk5OXB4IiBoZWlnaHQ9Ijk5OTk5cHgiIHZpZXdCb3g9IjAgMCA5OTk5OSA5OTk5OSIgdmVyc2lvbj0iMS4xIiB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHhtbG5zOnhsaW5rPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rIj48ZyBzdHJva2U9Im5vbmUiIGZpbGw9Im5vbmUiIGZpbGwtb3BhY2l0eT0iMCI+PHJlY3QgeD0iMCIgeT0iMCIgd2lkdGg9Ijk5OTk5IiBoZWlnaHQ9Ijk5OTk5Ij48L3JlY3Q+IDwvZz4gPC9zdmc+) [My Markets Watchlist](https://markets.businessinsider.com/mymarkets?originurl=/stocks/moh-stock) [DOW 30 -0.07%-34.2947,706.51](https://markets.businessinsider.com/index/dow_jones) [S\&P 500 -0.21%-14.506,793.50](https://markets.businessinsider.com/index/s&p_500) [NASDAQ 100 -0.04%-10.7824,956.47](https://markets.businessinsider.com/index/nasdaq_100) [gold +0.40%+20.905,209.27](https://markets.businessinsider.com/commodities/gold-price) [oil (wti) -0.84%-0.7082.75](https://markets.businessinsider.com/commodities/oil-price?type=wti) [BTC/USD +0.27%+191.8670,093.26](https://markets.businessinsider.com/currencies/btc-usd) [DOW 30 -0.07%-34.2947,706.51](https://markets.businessinsider.com/index/dow_jones) [S\&P 500 -0.21%-14.506,793.50](https://markets.businessinsider.com/index/s&p_500) [NASDAQ 100 -0.04%-10.7824,956.47](https://markets.businessinsider.com/index/nasdaq_100) [gold +0.40%+20.905,209.27](https://markets.businessinsider.com/commodities/gold-price) [oil (wti) -0.84%-0.7082.75](https://markets.businessinsider.com/commodities/oil-price?type=wti) [BTC/USD +0.27%+191.8670,093.26](https://markets.businessinsider.com/currencies/btc-usd) [Markets](https://markets.businessinsider.com/) [Stocks](https://markets.businessinsider.com/stocks) [Business](https://www.businessinsider.com/business) [Strategy](https://www.businessinsider.com/strategy) [Economy](https://www.businessinsider.com/economy) [Finance](https://www.businessinsider.com/finance) [Retail](https://www.businessinsider.com/retail) [Advertising](https://www.businessinsider.com/advertising) [Careers](https://www.businessinsider.com/careers) [Media](https://www.businessinsider.com/media) [Real Estate](https://www.businessinsider.com/real-estate) [Small Business](https://www.businessinsider.com/smallbusiness) [The Better Work Project](https://www.businessinsider.com/sc/introducing-the-better-work-project-hub) [Personal Finance](https://www.businessinsider.com/personal-finance) [Tech](https://www.businessinsider.com/tech) [Science](https://www.businessinsider.com/science) [AI](https://www.businessinsider.com/artificial-intelligence) [Enterprise](https://www.businessinsider.com/enterprise) [Transportation](https://www.businessinsider.com/transportation) [Startups](https://www.businessinsider.com/startups) [Innovation](https://www.businessinsider.com/innovation) [Markets](https://markets.businessinsider.com/) [Stocks](https://markets.businessinsider.com/stocks) [Indices](https://markets.businessinsider.com/indices) [Commodities](https://markets.businessinsider.com/commodities) [Crypto](https://markets.businessinsider.com/cryptocurrencies) [Currencies](https://markets.businessinsider.com/currencies) [ETFs](https://markets.businessinsider.com/etfs) [Lifestyle](https://www.businessinsider.com/lifestyle) [Entertainment](https://www.businessinsider.com/entertainment) [Culture](https://www.businessinsider.com/culture) [Travel](https://www.businessinsider.com/travel) [Food](https://www.businessinsider.com/food) [Health](https://www.businessinsider.com/health) [Parenting](https://www.businessinsider.com/parenting) [Politics](https://www.businessinsider.com/politics) [Military & Defense](https://www.businessinsider.com/defense) [Law](https://www.businessinsider.com/law) [Education](https://www.businessinsider.com/education) [Reviews](https://www.businessinsider.com/guides) [Home](https://markets.businessinsider.com/guides/home) [Kitchen](https://markets.businessinsider.com/guides/kitchen) [Style](https://markets.businessinsider.com/guides/style) [Streaming](https://markets.businessinsider.com/guides/streaming) [Pets](https://markets.businessinsider.com/guides/pets) [Tech](https://markets.businessinsider.com/guides/tech) [Deals](https://markets.businessinsider.com/guides/deals) [Gifts](https://markets.businessinsider.com/guides/gifts) [Tickets](https://markets.businessinsider.com/guides/tickets) [Video](https://www.businessinsider.com/video) [Big Business](https://www.businessinsider.com/show/big-business) [Food Wars](https://www.businessinsider.com/show/food-wars) [So Expensive](https://www.businessinsider.com/show/so-expensive) [Still Standing](https://www.businessinsider.com/show/still-standing) [Boot Camp](https://www.businessinsider.com/show/boot-camp) # Molina HealthcareStock , MOH 141\.32\-4.73\-3.24% 03:59:59 PM BTT Add to watchlist \| \| \| \| \| \| \|---\|---\|---\|---\|---\| \| [News](https://markets.businessinsider.com/stocks/moh-stock#instrument-detail-news) \| [Analyst Data](https://markets.businessinsider.com/stocks/moh-stock#analyst) \| [Analyst Opinions](https://markets.businessinsider.com/stocks/moh-stock#analyst_opinions) \| [Insider Activity](https://markets.businessinsider.com/stocks/moh-stock#insider_activity) \| [Dividend Calendar](https://markets.businessinsider.com/stocks/moh-stock#dividend_calendar) \| intraday 1w 1m 6m ytd 1y 3y 5y max Indicators - Moving Average - Momentum - MACD - Stochastics - RSI - Bollinger Bands - Supertrend - Average True R. - Volume Mountain-Chart - Mountain-Chart - Line-Chart - OHLC-Chart - Candlestick-Chart - Advanced Chart savecancel (right-click to deleteright-click to manage)(long-press to drag) Date Compare with Remove all Compare with up to 5 Stocks On Tuesday 03/10/2026 the closing price of the Molina Healthcare share was \$141.32 on BTT. Compared to the opening price on Tuesday 03/10/2026 on BTT of \$146.28, this is a drop of 3.51%. Molina Healthcare's market capitalization is \$5.83 B by 51.50 M shares outstanding. Is Molina Healthcare stock a Buy, Sell or Hold? Molina Healthcare stock has received a consensus rating of hold. The average rating score is and is based on 17 buy ratings, 33 hold ratings, and 5 sell ratings. What was the 52-week low for Molina Healthcare stock? The low in the last 52 weeks of Molina Healthcare stock was 121.16. According to the current price, Molina Healthcare is 116.64% away from the 52-week low. What was the 52-week high for Molina Healthcare stock? The high in the last 52 weeks of Molina Healthcare stock was 359.79. According to the current price, Molina Healthcare is 39.28% away from the 52-week high. What are analysts forecasts for Molina Healthcare stock? The 55 analysts offering price forecasts for Molina Healthcare have a median target of 285.16, with a high estimate of 440.00 and a low estimate of 124.00. The median estimate represents a 49.56 difference from the last price of 141.32. ## Molina Healthcare Stock Snapshot 134\.40 Bid 100\.00 Bid Size 148\.73 Ask 100\.00 Ask Size 3/10/2026 Date 3:59 PM Time 67,913.00 Volume 146\.05 Prev. Close 146\.28 Open 7\.52 B Market Cap in USD 51\.50 M Number of Shares 51\.50 M Total Number of Shares 137\.78 Day Low 146\.28 Day High 141\.32 121\.16 52 Week Low 359\.79 52 Week High 141\.32 0\.00 Dividend in USD 0\.00 Dividend Yield 19\.45 P/E Ratio 98\.54 Free Float in % 8\.92 EPS in USD 79\.78 Book Value per Share in USD \-10.11 Cash Flow per Share in USD ## Molina Healthcare News [More News](https://markets.businessinsider.com/news/moh-stock) TipRanks 4d ### [S\&P 500 Rebalancing: Who’s In, Who’s Out?](https://markets.businessinsider.com/news/stocks/s-p-500-rebalancing-who-s-in-who-s-out-1035907438) TipRanks 4d ### [S\&P 600 adding fifteen companies at open on 3/23](https://markets.businessinsider.com/news/stocks/s-p-600-adding-fifteen-companies-at-open-on-3-23-1035907434) TipRanks 4d ### [Vertiv, Lumentum, Coherent, EchoStar set to join S\&P 500 at open on 3/23](https://markets.businessinsider.com/news/stocks/vertiv-lumentum-coherent-echostar-set-to-join-s-p-500-at-open-on-3-23-1035907427) TipRanks 6d ### [Molina Healthcare price target lowered to \$128 from \$158 at Morgan Stanley](https://markets.businessinsider.com/news/stocks/molina-healthcare-price-target-lowered-to-128-from-158-at-morgan-stanley-1035897240) TipRanks 6d ### [Centene price target raised to \$45 from \$38 at Morgan Stanley](https://markets.businessinsider.com/news/stocks/centene-price-target-raised-to-45-from-38-at-morgan-stanley-1035897159) ## Historical Prices for Molina Healthcare Feb. 10 2026❮ ❯ Mar. 10 2026❮ ❯ Download Reset \| Date ▼ \| Open \| Close \| Daily High \| Daily Low \| Volume \| \|---\|---\|---\|---\|---\|---\| \| 03/06/26 \| 148\.04 \| 144\.47 \| 149\.11 \| 144\.47 \| 67,537.00 \| \| 03/05/26 \| 148\.80 \| 147\.74 \| 150\.81 \| 145\.52 \| 24,193.00 \| \| 03/04/26 \| 144\.30 \| 150\.03 \| 151\.33 \| 144\.07 \| 35,469.00 \| \| 03/03/26 \| 149\.21 \| 144\.83 \| 149\.47 \| 142\.53 \| 56,868.00 \| \| 03/02/26 \| 150\.80 \| 152\.31 \| 152\.53 \| 148\.72 \| 39,570.00 \| \| 02/27/26 \| 147\.55 \| 154\.13 \| 154\.90 \| 145\.98 \| 82,716.00 \| \| 02/26/26 \| 146\.00 \| 146\.21 \| 148\.69 \| 143\.91 \| 41,520.00 \| \| 02/25/26 \| 150\.21 \| 145\.59 \| 153\.12 \| 145\.11 \| 55,482.00 \| \| 02/24/26 \| 157\.64 \| 148\.44 \| 158\.00 \| 146\.82 \| 67,400.00 \| \| 02/23/26 \| 150\.86 \| 156\.22 \| 156\.93 \| 150\.51 \| 52,267.00 \| \| 02/20/26 \| 147\.10 \| 151\.10 \| 151\.10 \| 142\.64 \| 67,874.00 \| \| 02/19/26 \| 144\.89 \| 148\.24 \| 148\.49 \| 140\.99 \| 47,946.00 \| \| 02/18/26 \| 135\.73 \| 142\.61 \| 143\.04 \| 134\.19 \| 74,200.00 \| \| 02/17/26 \| 135\.07 \| 135\.68 \| 137\.17 \| 133\.18 \| 60,150.00 \| \| 02/13/26 \| 129\.32 \| 135\.37 \| 135\.38 \| 129\.32 \| 51,475.00 \| \| 02/12/26 \| 123\.01 \| 126\.76 \| 128\.74 \| 122\.95 \| 52,771.00 \| \| 02/11/26 \| 125\.25 \| 122\.56 \| 125\.84 \| 121\.16 \| 98,630.00 \| \| 02/10/26 \| 128\.44 \| 125\.34 \| 129\.01 \| 125\.34 \| 90,708.00 \| Price change over selected period: 15\.26%\+19.13 ## Molina Healthcare Analyst Data Total Analysts: 55 Buy Ratings: 17 Neutral Ratings: 33 Sell Ratings: 5 savecancel (right-click to deleteright-click to manage)(long-press to drag) Price Analyst: Wells Fargo & Co Price-Target: 440 Rating: neutral Analyst: Bank of America Merrill Lynch Price-Target: 439 Rating: sell Analyst: Bank of America Merrill Lynch Price-Target: 439 Rating: sell Analyst: Cantor Fitzgerald Price-Target: 406 Rating: buy Analyst: Wells Fargo & Co Price-Target: 410 Rating: neutral Analyst: Barclays Capital Price-Target: 430 Rating: neutral Analyst: Stephens Inc. Price-Target: 390 Rating: neutral Analyst: Wells Fargo & Co Price-Target: 375 Rating: neutral Analyst: Baird Patrick & Co Price-Target: 405 Rating: buy Analyst: J.P. Morgan Price-Target: 420 Rating: buy Analyst: J.P. Morgan Price-Target: 395 Rating: buy Analyst: Wells Fargo & Co Price-Target: 315 Rating: neutral Analyst: Cantor Fitzgerald Price-Target: 406 Rating: buy Analyst: Jefferies & Company Inc. Price-Target: 297 Rating: neutral Analyst: Stephens Inc. Price-Target: 320 Rating: neutral Analyst: Deutsche Bank Price-Target: 353 Rating: neutral Analyst: Stephens Inc. Price-Target: 345 Rating: neutral Analyst: UBS Price-Target: 325 Rating: neutral Analyst: Barclays Capital Price-Target: 339 Rating: neutral Analyst: Mizuho Price-Target: 376 Rating: buy Analyst: Wells Fargo & Co Price-Target: 372 Rating: buy Analyst: Mizuho Price-Target: 400 Rating: buy Analyst: Baird Patrick & Co Price-Target: 375 Rating: neutral Analyst: Bernstein Price-Target: 414 Rating: buy Analyst: Barclays Capital Price-Target: 362 Rating: neutral Analyst: Barclays Capital Price-Target: 351 Rating: neutral Analyst: Barclays Capital Price-Target: 347 Rating: neutral Analyst: Morgan Stanley Price-Target: 364 Rating: buy Analyst: Morgan Stanley Price-Target: 266 Rating: neutral Analyst: Mizuho Price-Target: 330 Rating: buy Analyst: Wells Fargo & Co Price-Target: 216 Rating: buy Analyst: Baird Patrick & Co Price-Target: 179 Rating: neutral Analyst: Barclays Capital Price-Target: 186 Rating: neutral Analyst: Cantor Fitzgerald Price-Target: 210 Rating: neutral Analyst: UBS Price-Target: 180 Rating: neutral Analyst: J.P. Morgan Price-Target: 184 Rating: neutral Analyst: Wells Fargo & Co Price-Target: 198 Rating: buy Analyst: Cantor Fitzgerald Price-Target: 210 Rating: neutral Analyst: Barclays Capital Price-Target: 185 Rating: neutral Analyst: Bernstein Price-Target: 220 Rating: buy Analyst: Wells Fargo & Co Price-Target: 231 Rating: buy Analyst: Morgan Stanley Price-Target: 204 Rating: neutral Analyst: Goldman Sachs Price-Target: 207 Rating: neutral Analyst: Barclays Capital Price-Target: 144 Rating: sell Analyst: UBS Price-Target: 170 Rating: neutral Analyst: Cantor Fitzgerald Price-Target: 180 Rating: neutral Analyst: Goldman Sachs Price-Target: 167 Rating: neutral Analyst: Wells Fargo & Co Price-Target: 165 Rating: buy Analyst: Barclays Capital Price-Target: 164 Rating: sell Analyst: Wells Fargo & Co Price-Target: 208 Rating: buy Analyst: Cantor Fitzgerald Price-Target: 144 Rating: neutral Analyst: Barclays Capital Price-Target: 133 Rating: sell Analyst: Goldman Sachs Price-Target: 124 Rating: neutral Analyst: Wells Fargo & Co Price-Target: 141 Rating: neutral Analyst: Morgan Stanley Price-Target: 128 Rating: neutral Analyst: {{ANALYST\_DATA}} Price-Target: {{PRICE\_DATA}} Rating: {{RATING\_DATA}} Price \Price Target Lowest: 124\.00 Median: 285\.16 Highest: 440\.00 \The average price target includes all analyst analysis, not just the most recent analysis presented in the chart. ## Molina Healthcare Analyst Opinions All - All - Buy - Hold - Sell \| Date \| \| Analyst \| \| Rating \| Price \| \| \|---\|---\|---\|---\|---\|---\|---\| \| 03/04/26 \| \| Morgan Stanley \| \| Maintained Hold \| \$128 \| neutral \| \| 02/20/26 \| \| Wells Fargo & Co \| \| Downgraded to Hold \| \$141 \| neutral \| \| 02/12/26 \| \| Goldman Sachs \| \| Maintained Hold \| \$124 \| neutral \| \| 02/10/26 \| \| Barclays Capital \| \| Maintained Sell \| \$133 \| schlecht \| \| 02/09/26 \| \| Cantor Fitzgerald \| \| Maintained Hold \| \$144 \| neutral \| \| 01/07/26 \| \| Wells Fargo & Co \| \| Maintained Buy \| \$208 \| gut \| \| 01/05/26 \| \| Barclays Capital \| \| Maintained Sell \| \$164 \| schlecht \| \| 11/12/25 \| \| Wells Fargo & Co \| \| Maintained Buy \| \$165 \| gut \| \| 10/24/25 \| \| Goldman Sachs \| \| Maintained Hold \| \$167 \| neutral \| \| 10/24/25 \| \| UBS \| \| Maintained Hold \| \$170 \| neutral \| \| 10/24/25 \| \| Cantor Fitzgerald \| \| Maintained Hold \| \$180 \| neutral \| \| 10/24/25 \| \| Barclays Capital \| \| Downgraded to Sell \| \$144 \| schlecht \| \| 10/14/25 \| \| Morgan Stanley \| \| Maintained Hold \| \$204 \| neutral \| \| 10/14/25 \| \| Goldman Sachs \| \| Maintained Hold \| \$207 \| neutral \| \| 10/07/25 \| \| Wells Fargo & Co \| \| Maintained Buy \| \$231 \| gut \| \| 09/05/25 \| \| Bernstein \| \| Maintained Buy \| \$220 \| gut \| \| 09/04/25 \| \| Barclays Capital \| \| Maintained Hold \| \$185 \| neutral \| \| 08/26/25 \| \| Cantor Fitzgerald \| \| Maintained Hold \| \$210 \| neutral \| \| 08/15/25 \| \| Wells Fargo & Co \| \| Maintained Buy \| \$198 \| gut \| \| 07/29/25 \| \| J.P. Morgan \| \| Maintained Hold \| \$184 \| neutral \| \| 07/25/25 \| \| UBS \| \| Maintained Hold \| \$180 \| neutral \| \| 07/25/25 \| \| Barclays Capital \| \| Maintained Hold \| \$186 \| neutral \| \| 07/25/25 \| \| Cantor Fitzgerald \| \| Downgraded to Hold \| \$210 \| neutral \| \| 07/25/25 \| \| Baird Patrick & Co \| \| Maintained Hold \| \$179 \| neutral \| \| 07/23/25 \| \| Wells Fargo & Co \| \| Maintained Buy \| \$216 \| gut \| \| 07/11/25 \| \| Mizuho \| \| Maintained Buy \| \$330 \| gut \| \| 07/10/25 \| \| Morgan Stanley \| \| Downgraded to Hold \| \$266 \| neutral \| \| 06/09/25 \| \| Barclays Capital \| \| Maintained Hold \| \$347 \| neutral \| \| 06/09/25 \| \| Morgan Stanley \| \| Maintained Buy \| \$364 \| gut \| \| 06/02/25 \| \| Barclays Capital \| \| Maintained Hold \| \$351 \| neutral \| \| 04/25/25 \| \| Barclays Capital \| \| Maintained Hold \| \$362 \| neutral \| \| 04/22/25 \| \| Bernstein \| \| Maintained Buy \| \$414 \| gut \| \| 04/15/25 \| \| Baird Patrick & Co \| \| Downgraded to Hold \| \$375 \| neutral \| \| 04/09/25 \| \| Guggenheim \| \| Maintained Hold \| \| neutral \| \| 04/09/25 \| \| Mizuho \| \| Maintained Buy \| \$400 \| gut \| \| 03/05/25 \| \| Wells Fargo & Co \| \| Upgraded to Buy \| \$372 \| gut \| \| 03/03/25 \| \| Mizuho \| \| Maintained Buy \| \$376 \| gut \| \| 02/07/25 \| \| Barclays Capital \| \| Maintained Hold \| \$339 \| neutral \| \| 02/07/25 \| \| UBS \| \| Maintained Hold \| \$325 \| neutral \| \| 02/06/25 \| \| Stephens Inc. \| \| Maintained Hold \| \$345 \| neutral \| \| 07/29/24 \| \| Deutsche Bank \| \| Maintained Hold \| \$353 \| neutral \| \| 07/25/24 \| \| Stephens Inc. \| \| Maintained Hold \| \$320 \| neutral \| \| 07/24/24 \| \| Jefferies & Company Inc. \| \| Maintained Hold \| \$297 \| neutral \| \| 07/23/24 \| \| Cantor Fitzgerald \| \| Maintained Buy \| \$406 \| gut \| \| 07/22/24 \| \| Wells Fargo & Co \| \| Maintained Hold \| \$315 \| neutral \| \| 07/10/24 \| \| J.P. Morgan \| \| Maintained Buy \| \$395 \| gut \| \| 05/30/24 \| \| J.P. Morgan \| \| Maintained Buy \| \$420 \| gut \| \| 05/30/24 \| \| Baird Patrick & Co \| \| Maintained Buy \| \$405 \| gut \| \| 04/29/24 \| \| Wells Fargo & Co \| \| Maintained Hold \| \$375 \| neutral \| \| 04/25/24 \| \| Barclays Capital \| \| Maintained Hold \| \$430 \| neutral \| ## Molina Healthcare Estimates\* in USD - Yearly - Quarterly \| \| 2026 \| 2027 \| 2028 \| 2029 \| 2030 \| \|---\|---\|---\|---\|---\|---\| \| Revenue \| 45,193 \| 48,090 \| 50,280 \| \- \| \- \| \| Dividend \| 0\.00 \| 0\.00 \| 0\.00 \| \- \| \- \| \| Dividend Yield (in %) \| 0\.00 % \| 0\.00 % \| 0\.00 % \| \- \| \- \| \| EPS \| 6\.16 \| 10\.40 \| 16\.54 \| 30\.50 \| \- \| \| P/E Ratio \| 23\.72 \| 14\.04 \| 8\.83 \| 4\.79 \| 5\.71 \| \| EBIT \| 667 \| 831 \| 1,180 \| 1,981 \| \- \| \| EBITDA \| 791 \| 910 \| 1,087 \| \- \| \- \| \| Net Profit \| 390 \| 510 \| 799 \| 1,378 \| \- \| \| Net Profit Adjusted \| 390 \| 510 \| 799 \| 1,378 \| \- \| \| Pre-Tax Profit \| 466 \| 662 \| 1,054 \| 1,795 \| \- \| \| Pre-Tax Profit Reported \| 242 \| 405 \| \- \| \- \| \- \| \| EPS (Non-GAAP) ex. SOE \| 10\.15 \| 13\.32 \| 12\.29 \| \- \| \- \| \| EPS (GAAP) \| 5\.80 \| 9\.47 \| 16\.38 \| \- \| \- \| \| Gross Income \| \- \| \- \| \- \| \- \| \- \| \| Cash Flow from Investing \| \-328 \| \-284 \| \-203 \| \- \| \- \| \| Cash Flow from Operations \| 552 \| 732 \| 865 \| \- \| \- \| \| Cash Flow from Financing \| \-285 \| \-281 \| \-68 \| \- \| \- \| \| Cash Flow per Share \| 5\.47 \| 13\.12 \| 17\.29 \| \- \| \- \| \| Free Cash Flow \| 509 \| 788 \| 1,040 \| \- \| \- \| \| Free Cash Flow per Share \| \- \| \- \| \- \| \- \| \- \| \| Book Value per Share \| 90\.68 \| 107\.16 \| 139\.93 \| \- \| \- \| \| Net Debt \| \-1,638 \| \-2,220 \| \-3,290 \| \- \| \- \| \| Research & Development Exp. \| \- \| \- \| \- \| \- \| \- \| \| Capital Expenditure \| 128 \| 140 \| 173 \| \- \| \- \| \| Selling, General & Admin. Exp. \| 3,486 \| 3,703 \| 3,044 \| \- \| \- \| \| Shareholder’s Equity \| 4,276 \| 4,621 \| 5,030 \| \- \| \- \| \| Total Assets \| 15,534 \| 15,974 \| 16,659 \| \- \| \- \| \| \| Previous Quarter ending 12/31/25 \| Current Quarter ending 03/31/26 \| Next Quarter ending 06/30/26 \| Current Year ending 12/31/26 \| Next Year ending 12/31/27 \| \|---\|---\|---\|---\|---\|---\| \| Earnings Estimates \| \| \| \| \| \| \| No. of Analysts \| \- \| 17 \| 17 \| 17 \| 18 \| \| Average Estimate \| \- \| 2\.601 USD \| 2\.098 USD \| 6\.617 USD \| 10\.399 USD \| \| Year Ago \| \- \| 5\.458 USD \| 4\.758 USD \| 8\.939 USD \| \- \| \| Publish Date \| \- \| 4/22/2026 \| 7/29/2026 \| \- \| \- \| \| Revenue Estimates \| \| \| \| \| \| \| No. of Analysts \| \- \| 11 \| 11 \| 16 \| 14 \| \| Average Estimate \| \- \| 11,016 USD \| 11,091 USD \| 45,193 USD \| 48,090 USD \| \| Year Ago \| \- \| 11,147 USD \| 11,427 USD \| 45,426 USD \| \- \| \| Publish Date \| \- \| 4/22/2026 \| 7/29/2026 \| \- \| \- \| \* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet ## Income Statements in Mio. USD \| \| 2025 \| 2024 \| 2023 \| 2022 \| 2021 \| 2020 \| 2019 \| \|---\|---\|---\|---\|---\|---\|---\|---\| \| Sales \| 45,426.00 \| 40,650.00 \| 34,072.00 \| 31,974.00 \| 27,771.00 \| 19,295.00 \| 16,829.00 \| \| Change of sales in % \| 11\.75 \| 19\.31 \| 6\.56 \| 15\.13 \| 43\.93 \| 14\.65 \| \-10.91 \| \| Gross profit on sales \| \- \| \- \| \- \| \- \| \- \| \- \| \- \| \| Gross profit on sales change in % \| \- \| \- \| \- \| \- \| \- \| \- \| \- \| \| Operating income \| 781\.00 \| 1,707.00 \| 1,573.00 \| 1,381.00 \| 1,020.00 \| 950\.00 \| 1,050.00 \| \| Operating income change in % \| \-54.25 \| 8\.52 \| 13\.90 \| 35\.39 \| 7\.37 \| \-9.52 \| \-11.91 \| \| Income before tax \| 589\.00 \| 1,589.00 \| 1,464.00 \| 1,063.00 \| 875\.00 \| 961\.00 \| 972\.00 \| \| Income before tax change in % \| \-62.93 \| 8\.54 \| 37\.72 \| 21\.49 \| \-8.95 \| \-1.13 \| \-2.70 \| \| Income after tax \| 472\.00 \| 1,179.00 \| 1,091.00 \| 792\.00 \| 659\.00 \| 673\.00 \| 737\.00 \| \| Income after tax change in % \| \-59.97 \| 8\.07 \| 37\.75 \| 20\.18 \| \-2.08 \| \-8.68 \| 4\.24 \| ## Balance Sheet in Mio. USD \| \| 2025 \| 2024 \| 2023 \| 2022 \| 2021 \| 2020 \| 2019 \| \|---\|---\|---\|---\|---\|---\|---\|---\| \| Total liabilities \| 11,541.00 \| 11,186.00 \| 10,720.00 \| 9,365.00 \| 9,593.00 \| 7,465.00 \| 4,836.00 \| \| Long-term liabilities per share \| \- \| \- \| \- \| \- \| \- \| \- \| \- \| \| Equity \| 4,069.00 \| 4,496.00 \| 4,215.00 \| 2,964.00 \| 2,630.00 \| 2,096.00 \| 1,960.00 \| \| Equity change in % \| \-9.50 \| 6\.67 \| 42\.21 \| 12\.70 \| 25\.48 \| 6\.94 \| 19\.00 \| \| Balance sheet total \| 15,610.00 \| 15,682.00 \| 14,935.00 \| 12,329.00 \| 12,223.00 \| 9,561.00 \| 6,796.00 \| \| Balance sheet total change in % \| \-0.46 \| 5\.00 \| 21\.14 \| 0\.87 \| 27\.84 \| 40\.69 \| \-5.08 \| ## Key Data in USD \| \| 2025 \| 2024 \| 2023 \| 2022 \| 2021 \| 2020 \| 2019 \| \|---\|---\|---\|---\|---\|---\|---\|---\| \| Sales per share \| 858\.71 \| 704\.51 \| 586\.44 \| 546\.56 \| 473\.91 \| 322\.12 \| 262\.13 \| \| P/E ratio (year end quote, basic EPS) \| 19\.45 \| 14\.24 \| 19\.24 \| 24\.39 \| 28\.28 \| 18\.93 \| 11\.82 \| \| P/E ratio (year end quote, diluted EPS) \| 19\.45 \| 14\.24 \| 19\.24 \| 24\.39 \| 28\.28 \| 18\.93 \| 11\.82 \| \| Dividend yield in % \| 0\.00 \| 0\.00 \| 0\.00 \| 0\.00 \| 0\.00 \| 0\.00 \| 0\.00 \| \| Equity ratio in % \| 26\.07 \| 28\.67 \| 28\.22 \| 24\.04 \| 21\.52 \| 21\.92 \| 28\.84 \| \| Debt ratio in % \| 73\.93 \| 71\.33 \| 71\.78 \| 75\.96 \| 78\.48 \| 78\.08 \| 71\.16 \| ## Molina Healthcare Insider Activity \| Name \| Date \| shares traded \| shares held \| Price \| type (sell/buy) \| option \| \|---\|---\|---\|---\|---\|---\|---\| \| [ZORETIC RICHARD C](https://markets.businessinsider.com/stocks/insideractivitytrader/zoretic-richard-c-596591) \| 02/10/2026 \| 800\.00 \| 8,747.00 \| 125\.16 \| Buy \| No \| \| [ZORETIC RICHARD C](https://markets.businessinsider.com/stocks/insideractivitytrader/zoretic-richard-c-596591) \| 12/31/2025 \| 317\.00 \| 7,947.00 \| 173\.54 \| Buy \| No \| \| [Lockhart Stephen H](https://markets.businessinsider.com/stocks/insideractivitytrader/lockhart-stephen-h-1158854) \| 12/31/2025 \| 317\.00 \| 3,742.00 \| 173\.54 \| Buy \| No \| \| [ROMNEY RONNA](https://markets.businessinsider.com/stocks/insideractivitytrader/romney-ronna-415986) \| 12/31/2025 \| 317\.00 \| 17,733.00 \| 173\.54 \| Buy \| No \| \| [ORLANDO STEVEN J](https://markets.businessinsider.com/stocks/insideractivitytrader/orlando-steven-j-389156) \| 12/31/2025 \| 317\.00 \| 17,325.00 \| 173\.54 \| Buy \| No \| \| [Bacon Debra](https://markets.businessinsider.com/stocks/insideractivitytrader/bacon-debra-1285131) \| 12/30/2025 \| 22\.00 \| 12,906.00 \| 147\.51 \| Buy \| No \| \| [Schapiro Richard M](https://markets.businessinsider.com/stocks/insideractivitytrader/schapiro-richard-m-972253) \| 11/23/2025 \| 357\.00 \| 11,352.00 \| 143\.02 \| Sell \| No \| \| [ROMNEY RONNA](https://markets.businessinsider.com/stocks/insideractivitytrader/romney-ronna-415986) \| 09/30/2025 \| 285\.00 \| 17,416.00 \| 192\.79 \| Buy \| No \| \| [ROMNEY RONNA](https://markets.businessinsider.com/stocks/insideractivitytrader/romney-ronna-415986) \| 08/05/2025 \| 700\.00 \| 17,131.00 \| 153\.74 \| Sell \| No \| \| [WOYS JAMES](https://markets.businessinsider.com/stocks/insideractivitytrader/woys-james-400394) \| 08/03/2025 \| 5,500.00 \| 69,831.00 \| 155\.59 \| Buy \| No \| \| [WOYS JAMES](https://markets.businessinsider.com/stocks/insideractivitytrader/woys-james-400394) \| 08/03/2025 \| 4,500.00 \| 74,331.00 \| 156\.36 \| Buy \| No \| \| [Bacon Debra](https://markets.businessinsider.com/stocks/insideractivitytrader/bacon-debra-1285131) \| 06/30/2025 \| 183\.00 \| 12,884.00 \| 306\.29 \| Sell \| No \| \| [WOLF DALE B](https://markets.businessinsider.com/stocks/insideractivitytrader/wolf-dale-b-417517) \| 06/30/2025 \| 180\.00 \| 14,389.00 \| 306\.29 \| Buy \| No \| \| [ORLANDO STEVEN J](https://markets.businessinsider.com/stocks/insideractivitytrader/orlando-steven-j-389156) \| 06/30/2025 \| 180\.00 \| 16,723.00 \| 306\.29 \| Buy \| No \| \| [Schapiro Richard M](https://markets.businessinsider.com/stocks/insideractivitytrader/schapiro-richard-m-972253) \| 06/30/2025 \| 180\.00 \| 11,424.00 \| 306\.29 \| Buy \| No \| \| [Bacon Debra](https://markets.businessinsider.com/stocks/insideractivitytrader/bacon-debra-1285131) \| 06/29/2025 \| 41\.00 \| 13,067.00 \| 247\.39 \| Buy \| No \| \| [Barlow Jeff D.](https://markets.businessinsider.com/stocks/insideractivitytrader/barlow-jeff-d.-887526) \| 06/29/2025 \| 85\.00 \| 72,902.00 \| 247\.39 \| Buy \| No \| \| [WOLF DALE B](https://markets.businessinsider.com/stocks/insideractivitytrader/wolf-dale-b-417517) \| 05/20/2025 \| 100\.00 \| 14,209.00 \| 324\.42 \| Sell \| No \| \| [WOLF DALE B](https://markets.businessinsider.com/stocks/insideractivitytrader/wolf-dale-b-417517) \| 05/20/2025 \| 900\.00 \| 14,309.00 \| 323\.27 \| Sell \| No \| \| [WOLF DALE B](https://markets.businessinsider.com/stocks/insideractivitytrader/wolf-dale-b-417517) \| 05/20/2025 \| 400\.00 \| 15,209.00 \| 322\.23 \| Sell \| No \| \| [WOLF DALE B](https://markets.businessinsider.com/stocks/insideractivitytrader/wolf-dale-b-417517) \| 05/20/2025 \| 100\.00 \| 15,609.00 \| 320\.51 \| Sell \| No \| \| [GROHOWSKI LEO P](https://markets.businessinsider.com/stocks/insideractivitytrader/grohowski-leo-p-422931) \| 04/30/2025 \| 118\.00 \| 118\.00 \| 313\.04 \| Buy \| No \| \| [Zubretsky Joseph M](https://markets.businessinsider.com/stocks/insideractivitytrader/zubretsky-joseph-m-667743) \| 04/29/2025 \| 86,400.00 \| 258,815.00 \| 320\.00 \| Sell \| No \| \| [Zubretsky Joseph M](https://markets.businessinsider.com/stocks/insideractivitytrader/zubretsky-joseph-m-667743) \| 04/29/2025 \| 1,100.00 \| 257,715.00 \| 324\.70 \| Sell \| No \| \| [Schapiro Richard M](https://markets.businessinsider.com/stocks/insideractivitytrader/schapiro-richard-m-972253) \| 04/28/2025 \| 669\.00 \| 11,244.00 \| 320\.50 \| Sell \| No \| ## Molina Healthcare Dividend Calendar \| Date \| Name \| Dividend \| \yield \| Currency \| \|---\|---\|---\|---\|---\| \| 2025 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2024 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2023 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2022 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2021 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2020 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2019 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2018 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2017 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2016 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2015 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2014 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2013 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2012 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2011 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2010 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2009 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \| 2008 \| Molina Healthcare \| 0\.00 \| 0\.00 \| USD \| \Yield of the Respective Date ## Molina Healthcare Calendar \| Event \| Estimate \| Info \| Date \| \|---\|---\|---\|---\| \| Earnings Report \| 2\.524 USD \| Q1 2026 Earnings Release \| 04/22/2026 \| \| Earnings Report \| 1\.976 USD \| Q2 2026 Earnings Release \| 07/29/2026 \| \| Earnings Report \| 1\.321 USD \| Q3 2026 Earnings Release \| 10/28/2026 \| \| Earnings Report \| 0\.321 USD \| Q4 2026 Earnings Release \| 02/10/2027 \| \| Earnings Report \| 3\.174 USD \| Q1 2027 Earnings Release \| 04/28/2027 \| ## Molina Healthcare Past Events \| Event \| Actual EPS \| Info \| Date \| \|---\|---\|---\|---\| \| Earnings Report \| \-3.150 USD \| Q4 2025 Earnings Release \| 02/05/2026 \| \| Earnings Report \| 1\.510 USD \| Q3 2025 Earnings Release \| 10/22/2025 \| \| Earnings Report \| 4\.750 USD \| Q2 2025 Earnings Release \| 07/23/2025 \| \| Annual General Meeting \| 20\.420 USD \| Annual General Meeting \| 04/30/2025 \| \| Earnings Report \| 5\.450 USD \| Q1 2025 Earnings Release \| 04/23/2025 \| \| Earnings Report \| 4\.440 USD \| Q4 2024 Earnings Release \| 02/05/2025 \| \| Earnings Report \| 5\.650 USD \| Q3 2024 Earnings Release \| 10/23/2024 \| \| Earnings Report \| 5\.170 USD \| Q2 2024 Earnings Release \| 07/24/2024 \| \| Annual General Meeting \| 18\.770 USD \| Annual General Meeting \| 05/01/2024 \| \| Earnings Report \| 5\.170 USD \| Q1 2024 Earnings Release \| 04/24/2024 \| \| Earnings Report \| 3\.700 USD \| Q4 2023 Earnings Release \| 02/07/2024 \| \| Earnings Report \| 4\.210 USD \| Q3 2023 Earnings Release \| 10/25/2023 \| \| Earnings Report \| 5\.350 USD \| Q2 2023 Earnings Release \| 07/26/2023 \| \| Annual General Meeting \| 13\.550 USD \| Annual General Meeting \| 05/03/2023 \| \| Earnings Report \| 5\.520 USD \| Q1 2023 Earnings Release \| 04/26/2023 \| \| Earnings Report \| 0\.960 USD \| Q4 2022 Earnings Release \| 02/08/2023 \| \| Earnings Report \| 3\.950 USD \| Q3 2022 Earnings Release \| 10/26/2022 \| \| Earnings Report \| 4\.250 USD \| Q2 2022 Earnings Release \| 07/27/2022 \| \| Annual General Meeting \| 11\.250 USD \| Annual General Meeting \| 05/04/2022 \| \| Earnings Report \| 4\.390 USD \| Q1 2022 Earnings Release \| 04/27/2022 \| \| Earnings Report \| 1\.740 USD \| Q4 2021 Earnings Release \| 02/09/2022 \| ## Molina Healthcare Profile Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA. ## Moody’s Daily Credit Risk Score Risk - Low - Medium - High 4 Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure. ## Molina Healthcare Management \| Name \| Job \| \|---\|---\| \| Maurice S. Hebert \| Chief Accounting Officer \| \| Mark L. Keim \| Chief Financial Officer & Senior Executive VP \| \| Lawrence D. Anderson \| Chief Human Resources Officer \| \| Carolyn Ingram \| Chief Marketing Officer \| \| Jason Dees \| Chief Medical Officer \| \| James E. Woys \| Chief Operating Officer \| \| Ronald M. Kurtz \| Chief of Staff \| \| Leo P. Grohowski \| Director \| \| Debra J. Bacon \| Executive Vice President-Medicaid \| \| Richard C. Zoretic \| Independent Director \| \| Richard M. Schapiro \| Independent Director \| \| Barbara L. Brasier \| Independent Director \| \| Stephen H. Lockhart \| Independent Director \| \| Steven J. Orlando \| Independent Director \| \| Dale B. Wolf \| Non-Executive Chairman \| \| Joseph M. Zubretsky \| President, Chief Executive Officer & Director \| \| Jeff D. Barlow \| Secretary & Chief Legal Officer \| \| Steve O'Dell \| Senior VP-Growth & Corporate Development \| \| Ronna E. Romney \| Vice Chairman \| \| Jeffrey Geyer \| Vice President-Investor Relations \| [![Click to visit Markets Insider](https://markets.businessinsider.com/public/assets/MI/logos/markets-insider-stacked.svg) ![](https://markets.businessinsider.com/public/assets/MI/logos/markets-insider-stacked.svg)](https://markets.businessinsider.com/) [![Facebook](https://markets.businessinsider.com/public/assets/social/social-facebook.svg) ![](https://markets.businessinsider.com/public/assets/social/social-facebook.svg)](https://www.facebook.com/MrktsInsider "Follow us on Facebook") [![X](https://markets.businessinsider.com/public/assets/social/social-x.svg) ![](https://markets.businessinsider.com/public/assets/social/social-x.svg)](https://x.com/mktsinsider "Follow us on X") * [Indices](https://markets.businessinsider.com/indices) [Dow Jones](https://markets.businessinsider.com/index/dow_jones) [S\&P 500](https://markets.businessinsider.com/index/s&p_500) [Nasdaq 100](https://markets.businessinsider.com/index/nasdaq_100) [Nasdaq Composite](https://markets.businessinsider.com/index/nasdaq_composite) [FTSE 100](https://markets.businessinsider.com/index/ftse_100) [Nikkei 225](https://markets.businessinsider.com/index/nikkei_225) [DAX 40](https://markets.businessinsider.com/index/dax) [Hang Seng](https://markets.businessinsider.com/index/hang_seng) [Kospi](https://markets.businessinsider.com/index/kospi) [S\&P TSX Composite Index](https://markets.businessinsider.com/index/s&p_tsx_composite_index) [ASX](https://markets.businessinsider.com/index/asx) [US Dollar Index](https://markets.businessinsider.com/index/us-dollar-index) [Stock Indices](https://markets.businessinsider.com/indices) [Dow Futures](https://markets.businessinsider.com/futures/dow-futures) [Dow Jones Market Movers](https://markets.businessinsider.com/market-movers/dow_jones) [Commodities](https://markets.businessinsider.com/commodities) [Gold Price](https://markets.businessinsider.com/commodities/gold-price) [Oil Price](https://markets.businessinsider.com/commodities/oil-price?type=wti) [Silver Price](https://markets.businessinsider.com/commodities/silver-price) [Copper Price](https://markets.businessinsider.com/commodities/copper-price) [Cotton Price](https://markets.businessinsider.com/commodities/cotton-price) [Heating Oil Price](https://markets.businessinsider.com/commodities/heating-oil-price) [Aluminum Price](https://markets.businessinsider.com/commodities/aluminum-price) [Natural Gas Price](https://markets.businessinsider.com/commodities/natural-gas-price) [Realtime Commodity Prices](https://markets.businessinsider.com/commodities/realtime-list) [Currencies](https://markets.businessinsider.com/currencies) [EURO DOLLAR](https://markets.businessinsider.com/currencies/eur-usd) [Bitcoin Price](https://markets.businessinsider.com/currencies/btc-usd) [ETH USD](https://markets.businessinsider.com/currencies/eth-usd) [CAD USD](https://markets.businessinsider.com/currencies/usd-cad) [PESO USD](https://markets.businessinsider.com/currencies/usd-mxn) [POUND USD](https://markets.businessinsider.com/currencies/gbp-usd) [USD INR](https://markets.businessinsider.com/currencies/usd-inr) [Currency Converter](https://markets.businessinsider.com/currency-converter) [Exchange Rates](https://markets.businessinsider.com/currencies) [Stocks](https://markets.businessinsider.com/stocks) [Google Stock](https://markets.businessinsider.com/stocks/goog-stock) [Meta Stock](https://markets.businessinsider.com/stocks/meta-stock) [Amazon Stock](https://markets.businessinsider.com/stocks/amzn-stock) [Tesla Stock](https://markets.businessinsider.com/stocks/tsla-stock) [Dow-Stock](https://markets.businessinsider.com/stocks/dow-stock) [Premarket](https://markets.businessinsider.com/premarket) [Stock Market News](https://markets.businessinsider.com/news) See more categories * [Copyright © 2026](https://businessinsider.com/terms) Insider Inc and [finanzen.net](https://www.finanzen.net/impressum) GmbH (Imprint). All rights reserved. Registration on or use of this site constitutes acceptance of our [Terms of Service](https://www.businessinsider.com/terms) and [Privacy Policy.](https://www.businessinsider.com/privacy-policy) [Disclaimer](https://www.businessinsider.com/disclaimer) [Accessibility](https://www.businessinsider.com/accessibility) [Commerce Policy](https://www.businessinsider.com/commerce-policy) [Advertising Policies](https://www.businessinsider.com/advertising-policies) Stock quotes by [finanzen.net](https://www.finanzen.net/) [Contact Us](https://www.businessinsider.com/contact) [Masthead](https://www.businessinsider.com/masthead) Cookie Settings ![Business Insider Logo](https://markets.businessinsider.com/public/assets/logos/stacked-black.svg) ![](https://markets.businessinsider.com/public/assets/logos/stacked-black.svg) ![Insider Logo](https://markets.businessinsider.com/public/assets/INSIDER/US/logos/Insider-logo-dark-opt.svg) ![](https://markets.businessinsider.com/public/assets/INSIDER/US/logos/Insider-logo-dark-opt.svg)
Readable Markdown	Price Analyst: Wells Fargo & Co Price-Target: 440 Rating: neutral Analyst: Bank of America Merrill Lynch Price-Target: 439 Rating: sell Analyst: Bank of America Merrill Lynch Price-Target: 439 Rating: sell Analyst: Cantor Fitzgerald Price-Target: 406 Rating: buy Analyst: Wells Fargo & Co Price-Target: 410 Rating: neutral Analyst: Barclays Capital Price-Target: 430 Rating: neutral Analyst: Stephens Inc. Price-Target: 390 Rating: neutral Analyst: Wells Fargo & Co Price-Target: 375 Rating: neutral Analyst: Baird Patrick & Co Price-Target: 405 Rating: buy Analyst: J.P. Morgan Price-Target: 420 Rating: buy Analyst: J.P. Morgan Price-Target: 395 Rating: buy Analyst: Wells Fargo & Co Price-Target: 315 Rating: neutral Analyst: Cantor Fitzgerald Price-Target: 406 Rating: buy Analyst: Jefferies & Company Inc. Price-Target: 297 Rating: neutral Analyst: Stephens Inc. Price-Target: 320 Rating: neutral Analyst: Deutsche Bank Price-Target: 353 Rating: neutral Analyst: Stephens Inc. Price-Target: 345 Rating: neutral Analyst: UBS Price-Target: 325 Rating: neutral Analyst: Barclays Capital Price-Target: 339 Rating: neutral Analyst: Mizuho Price-Target: 376 Rating: buy Analyst: Wells Fargo & Co Price-Target: 372 Rating: buy Analyst: Mizuho Price-Target: 400 Rating: buy Analyst: Baird Patrick & Co Price-Target: 375 Rating: neutral Analyst: Bernstein Price-Target: 414 Rating: buy Analyst: Barclays Capital Price-Target: 362 Rating: neutral Analyst: Barclays Capital Price-Target: 351 Rating: neutral Analyst: Barclays Capital Price-Target: 347 Rating: neutral Analyst: Morgan Stanley Price-Target: 364 Rating: buy Analyst: Morgan Stanley Price-Target: 266 Rating: neutral Analyst: Mizuho Price-Target: 330 Rating: buy Analyst: Wells Fargo & Co Price-Target: 216 Rating: buy Analyst: Baird Patrick & Co Price-Target: 179 Rating: neutral Analyst: Barclays Capital Price-Target: 186 Rating: neutral Analyst: Cantor Fitzgerald Price-Target: 210 Rating: neutral Analyst: UBS Price-Target: 180 Rating: neutral Analyst: J.P. Morgan Price-Target: 184 Rating: neutral Analyst: Wells Fargo & Co Price-Target: 198 Rating: buy Analyst: Cantor Fitzgerald Price-Target: 210 Rating: neutral Analyst: Barclays Capital Price-Target: 185 Rating: neutral Analyst: Bernstein Price-Target: 220 Rating: buy Analyst: Wells Fargo & Co Price-Target: 231 Rating: buy Analyst: Morgan Stanley Price-Target: 204 Rating: neutral Analyst: Goldman Sachs Price-Target: 207 Rating: neutral Analyst: Barclays Capital Price-Target: 144 Rating: sell Analyst: UBS Price-Target: 170 Rating: neutral Analyst: Cantor Fitzgerald Price-Target: 180 Rating: neutral Analyst: Goldman Sachs Price-Target: 167 Rating: neutral Analyst: Wells Fargo & Co Price-Target: 165 Rating: buy Analyst: Barclays Capital Price-Target: 164 Rating: sell Analyst: Wells Fargo & Co Price-Target: 208 Rating: buy Analyst: Cantor Fitzgerald Price-Target: 144 Rating: neutral Analyst: Barclays Capital Price-Target: 133 Rating: sell Analyst: Goldman Sachs Price-Target: 124 Rating: neutral Analyst: Wells Fargo & Co Price-Target: 141 Rating: neutral Analyst: Morgan Stanley Price-Target: 128 Rating: neutral
Shard	181 (laksa)
Root Hash	15170859634011428381
Unparsed URL	com,businessinsider!markets,/stocks/moh-stock s443